{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T19:14:52Z","timestamp":1787685292598,"version":"build-2784847793"},"reference-count":193,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T00:00:00Z","timestamp":1724803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T00:00:00Z","timestamp":1724803200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100010607","name":"Universit\u00e0 degli Studi di Perugia","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100010607","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiol med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Multi-modal therapies for gynecological cancers management may determine a wide range of side effects which depend on therapy-related factors and patient characteristics and comorbidities. Curative or adjuvant pelvic radiotherapy is linked with acute and late toxicity due to irradiation of organs at risk, as small and large bowel, rectum, bladder, pelvic bone, vagina and bone marrow. Successful toxicity management varies with its severity, Radiation Centre practice and experience and skills of radiation oncologists. This position paper was designed by the Italian Association of Radiation and Clinical Oncology Gynecology Study Group to provide radiation oncologists with evidence-based strategies to prevent and manage acute and late toxicities and follow-up recommendations for gynecological cancer patients submitted radiotherapy. Six workgroups of radiation oncologists with over 5\u00a0years of experience in gynecologic cancers were setup to investigate radiotherapy-related toxicities. For each topic, PubMed database was searched for relevant English language papers from January 2005 to December 2022. Titles and abstracts of results were checked to verify suitability for the document. Reference lists of selected studies and review papers were added if pertinent. Data on incidence, etiopathogenesis, prevention, treatment and follow-up of acute and late side effects for each organ at risk are presented and discussed.<\/jats:p>","DOI":"10.1007\/s11547-024-01844-5","type":"journal-article","created":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T12:02:16Z","timestamp":1724846536000},"page":"1329-1351","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Prevention and management of radiotherapy-related toxicities in gynecological malignancies. Position paper on behalf of AIRO (Italian Association of Radiotherapy and Clinical Oncology)"],"prefix":"10.1007","volume":"129","author":[{"given":"Elisabetta","family":"Perrucci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Macchia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annamaria","family":"Cerrotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela Damiana","family":"Andrulli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Autorino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelia","family":"Barcellini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maura","family":"Campitelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Corrao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Costantini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vitaliana","family":"De Sanctis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacopo","family":"Di Muzio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-1172-3246","authenticated-orcid":false,"given":"Valeria","family":"Epifani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Ferrazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrei","family":"Fodor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Garibaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Concetta","family":"Laliscia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Lazzari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Magri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Mariucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Paola","family":"Pace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigida","family":"Pappalardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Pastorino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Piccolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Scoglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Surgo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Titone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Tortoreto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"De Felice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Aristei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,28]]},"reference":[{"key":"1844_CR1","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.clon.2021.04.009","volume":"33","author":"DCR Fernandes","year":"2021","unstructured":"Fernandes DCR, Andreyev HJN (2021) Gastrointestinal toxicity of pelvic radiotherapy: are we letting women down? Clin Oncol 33:591\u2013601. https:\/\/doi.org\/10.1016\/j.clon.2021.04.009","journal-title":"Clin Oncol"},{"key":"1844_CR2","doi-asserted-by":"publisher","first-page":"3870","DOI":"10.1002\/cncr.28849","volume":"120","author":"AN Viswanathan","year":"2014","unstructured":"Viswanathan AN, Lee LJ, Eswara JR, Horowitz NS, Konstantinopoulos PA, Mirabeau-Beale KL, Rose BS, von Keudell AG, Wo JY (2014) Complications of pelvic radiation in patients treated for gynecologic malignancies. Cancer 120:3870\u20133883. https:\/\/doi.org\/10.1002\/cncr.28849","journal-title":"Cancer"},{"key":"1844_CR3","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.semradonc.2017.04.010","volume":"27","author":"S Nicholas","year":"2017","unstructured":"Nicholas S, Chen L, Choflet A et al (2017) Pelvic radiation and normal tissue toxicity. Sem Rad Oncol 27:358\u2013369. https:\/\/doi.org\/10.1016\/j.semradonc.2017.04.010","journal-title":"Sem Rad Oncol"},{"key":"1844_CR4","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/0360-3016(95)00060-C","volume":"31","author":"JD Cox","year":"1995","unstructured":"Cox JD, Stetz J, Pajak TF (1995) Toxicity criteria of the radiation therapy oncology group (RTOG) and the European organization for research and treatment of cancer (EORTC). Int J Radiat Oncol Biol Phys 31:1341\u20131346. https:\/\/doi.org\/10.1016\/0360-3016(95)00060-C","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1844_CR5","unstructured":"Common Terminology Criteria for Adverse Events (CTCAE)http:\/\/evs.nci.nih.gov\/ftp1\/CTCAE: U.S. Department of Health and Human Services (2017) updated November 27, 2017. v5: Available from: https:\/\/ctep.cancer.gov\/protocoldevelopment\/electronic_applications\/docs\/CTCAE_v5_Quick_Reference_5x7.pdf"},{"issue":"5","key":"1844_CR6","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/0360-3016(95)00057-6","volume":"31","author":"P Rubin","year":"1995","unstructured":"Rubin P, Constine LS, Fajardo LF, Phillips TL, Wasserman TH (1995) Overview: late effects of normal tissues (LENT) scoring system. Int J Radiat Oncol Bio Phys 31(5):1041\u20131042. https:\/\/doi.org\/10.1016\/0360-3016(95)00057-6","journal-title":"Int J Radiat Oncol Bio Phys"},{"key":"1844_CR7","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s00066-017-1143-8","volume":"193","author":"L Sung Uk","year":"2017","unstructured":"Sung Uk L, Young Ae K, Young-Ho Y, Yeon-Joo K, Myong Cheol L, Sang-Yoon P, Sang-Soo S, Ji Eun P, Joo-Young K (2017) General health status of long-term cervical cancer survivors after radiotherapy. Strahlenther Onkol 193:543\u2013551. https:\/\/doi.org\/10.1007\/s00066-017-1143-8","journal-title":"Strahlenther Onkol"},{"key":"1844_CR8","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1097\/IGC.0b013e3182a80a65","volume":"23","author":"QD Pieterse","year":"2013","unstructured":"Pieterse QD, Kenter GG, Maas CP, de Kroon CD, Creutzberg CL, Trimbos JB, Ter Kuile MM (2013) Self-reported sexual, bowel and bladder function in cervical cancer patients following different treatment modalities: longitudinal prospective cohort study. Int J Gynecol Cancer 23:1717\u20131725. https:\/\/doi.org\/10.1097\/IGC.0b013e3182a80a65","journal-title":"Int J Gynecol Cancer"},{"key":"1844_CR9","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1097\/CCO.0000000000000215","volume":"27","author":"A Fernandes","year":"2015","unstructured":"Fernandes A, Bhuva NJ, Taylor A (2015) Management of toxicities following pelvic irradiation for gynaecological cancers. Curr Opin Oncol 27:405\u2013411. https:\/\/doi.org\/10.1097\/CCO.0000000000000215","journal-title":"Curr Opin Oncol"},{"key":"1844_CR10","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.rpor.2012.07.005","volume":"17","author":"A Roszak","year":"2012","unstructured":"Roszak A, Ware\u0144czak-Florczak Z, Bratos K, Milecki P (2012) Incidence of radiation toxicity in cervical cancer and endometrial cancer patients treated with radiotherapy alone versus adjuvant radiotherapy. Reports Pract. Oncol. Radiother 17:332\u2013338. https:\/\/doi.org\/10.1016\/j.rpor.2012.07.005","journal-title":"Reports Pract. Oncol. Radiother"},{"key":"1844_CR11","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1186\/s12885-021-08757-w","volume":"21","author":"YJ Kim","year":"2021","unstructured":"Kim YJ, Yu J, Park SP, Lee SH, Kim YS (2021) Prevention of radiotherapy induced enteropathy by probiotics (PREP): protocol for a double-blind randomized placebo-controlled trial. BMC Cancer. 21:1032. https:\/\/doi.org\/10.1186\/s12885-021-08757-w","journal-title":"BMC Cancer."},{"key":"1844_CR12","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1007\/s12602-018-9408-9","volume":"11","author":"YH Linn","year":"2019","unstructured":"Linn YH, Thu KK, Win NHH (2019) Effect of probiotics for the prevention of acute radiation-induced diarrhoea among cervical cancer patients: a randomized double-blind placebo-controlled study. Probiotics Antimicrob Proteins 11:638\u2013647. https:\/\/doi.org\/10.1007\/s12602-018-9408-9","journal-title":"Probiotics Antimicrob Proteins"},{"key":"1844_CR13","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/ejcn.2015.192","volume":"70","author":"P Garcia-Peris","year":"2016","unstructured":"Garcia-Peris P, Velasco C, Hernandez M, Lozano MA, Paron L, de la Cuerda C, Breton I, Camblor M, Guarner F (2016) Effect of inulin and fructo-oligosaccharide on the prevention of acute radiation enteritis in patients with gynecological cancer and impact on quality-of-life: a randomized, double-blind, placebo-controlled trial. Eur J Clin Nutr 70:170\u2013174. https:\/\/doi.org\/10.1038\/ejcn.2015.192","journal-title":"Eur J Clin Nutr"},{"issue":"36","key":"1844_CR14","doi-asserted-by":"publisher","first-page":"2538","DOI":"10.1200\/JCO.2017.77.4273","volume":"20","author":"AH Klopp","year":"2018","unstructured":"Klopp AH, Yeung AR, Deshmukh S, Gil KM, Wenzel L, Westin SN, Gifford K, Gaffney DK, Small W Jr, Thompson S, Doncals DE, Cantuaria GHC, Yaremko BP, Chang A, Kundapur V, Mohan DS, Haas ML, Kim YB, Ferguson CL, Pugh SL, Kachnic LA, Bruner DW (2018) Patient-reported toxicity during pelvic intensity-modulated radiation therapy: NRG oncology-RTOG 1203. J Clin Oncol 20(36):2538\u20132544. https:\/\/doi.org\/10.1200\/JCO.2017.77.4273","journal-title":"J Clin Oncol"},{"key":"1844_CR15","first-page":"1292","volume":"127","author":"G Macchia","year":"2022","unstructured":"Macchia G, Cas\u00e0 C, Ferioli M et al (2022) Observational multicenter Italian study on vulvar cancer adjuvant radiotherapy (OLDLADY 1.2): a cooperation among AIRO Gyn. MITO MaNGO gr 127:1292\u20131302","journal-title":"MITO MaNGO gr"},{"key":"1844_CR16","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1016\/j.ijrobp.2005.11.007","volume":"64","author":"S Beriwal","year":"2006","unstructured":"Beriwal S, Heron DE, Kim H et al (2006) Intensity-modulated radiotherapy for the treatment of vulvar carcinoma: a comparative dosimetric study with early clinical outcome. Int J Radiat Oncol Biol Phys 64:1395\u20131400","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1844_CR17","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1136\/ijgc-2023-004956","volume":"34","author":"V Lancellotta","year":"2024","unstructured":"Lancellotta V, Macchia G, Garganese G et al (2024) TRImodal DEfinitive invasive vagiNal carcinoma Treatment (TRIDENT protocol): how a standardized approach may change prognostic outcome. Int J Gynecol Cancer 34:197\u2013202","journal-title":"Int J Gynecol Cancer"},{"key":"1844_CR18","doi-asserted-by":"publisher","first-page":"101086","DOI":"10.1016\/j.gore.2022.101086","volume":"44","author":"NS McCall","year":"2022","unstructured":"McCall NS, Eng TY, Shelton JW et al (2022) Incidence and predictors of toxicity in the management of vulvar squamous cell carcinoma treated with radiation therapy. Gynecol Oncol Rep 44:101086","journal-title":"Gynecol Oncol Rep"},{"issue":"1","key":"1844_CR19","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.clon.2009.10.003","volume":"22","author":"VS Theis","year":"2010","unstructured":"Theis VS, Sripadam R, Ramani V, Lai S (2010) (2010) Chronic radiation enteritis. Clin Oncol (R Coll Radiol) 22(1):70\u201383. https:\/\/doi.org\/10.1016\/j.clon.2009.10.003","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"1844_CR20","doi-asserted-by":"publisher","first-page":"912","DOI":"10.3748\/wjg.v13.i6.912","volume":"13","author":"P Delia","year":"2007","unstructured":"Delia P, Sansotta G, Donato V, Frosina P, Messina G, De Renzis C, Famularo G (2007) Use of probiotics for prevention of radiation-induced diarrhea. World J Gastroenterol 13:912\u2013915","journal-title":"World J Gastroenterol"},{"key":"1844_CR21","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1748-717X-5-31","volume":"5","author":"I Chitapanarux","year":"2010","unstructured":"Chitapanarux I, Chitapanarux T, Traisathit P, Kudumpee S, Tharavichitkul E, Lorvidhaya V (2010) Randomized controlled trial of live lactobacillus acidophilus plus bifidobacterium bifidum in prophylaxis of diarrhea during radiotherapy in cervical cancer patients. Radiat Oncol 5:31. https:\/\/doi.org\/10.1186\/1748-717X-5-31","journal-title":"Radiat Oncol"},{"key":"1844_CR22","first-page":"5687","volume":"35","author":"D Scartoni","year":"2015","unstructured":"Scartoni D, Desideri I, Giacomelli I, Di Cataldo V, Di Brina L, Mancuso A, Furfaro I, Bonomo P, Simontacchi G, Livi L (2015) Nutritional supplement based on zinc, prebiotics, probiotics and vitamins to prevent radiation-related gastrointestinal disorders. Anticancer Res 35:5687\u20135692","journal-title":"Anticancer Res"},{"key":"1844_CR23","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1517\/17425255.4.10.1341","volume":"4","author":"LK Mell","year":"2008","unstructured":"Mell LK, Movsas B (2008) Pharmacologic normal tissue protection in clinical radiation oncology: focus on amifostine. Expert Opin Drug Metab Toxicol 4:1341\u20131350. https:\/\/doi.org\/10.1517\/17425255.4.10.1341","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"1844_CR24","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1016\/j.ijrobp.2021.03.031","volume":"110","author":"N Chaudary","year":"2021","unstructured":"Chaudary N, Hill RP, Stulik L, Milosevic M (2021) The oral CXCR4 inhibitor X4\u2013136 improves tumor control and reduces toxicity in cervical cancer treated with radiation therapy and concurrent chemotherapy. Int J Radiat Oncol Biol Phys 110:1317\u20131324. https:\/\/doi.org\/10.1016\/j.ijrobp.2021.03.031","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1844_CR25","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.ijrobp.2005.04.025","volume":"64","author":"L van de Bunt","year":"2006","unstructured":"van de Bunt L, van der Heide UA, Ketelaars M, de Kort GAP, J\u00fcrgenliemk-Schulz IM (2006) Conventional, conformal, and intensity-modulated radiation therapy treatment planning of external beam radiotherapy for cervical cancer: The impact of tumor regression. Int J Radiat Oncol Biol Phys 64:189\u2013196. https:\/\/doi.org\/10.1016\/j.ijrobp.2005.04.025","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1844_CR26","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1016\/j.ijrobp.2004.12.029","volume":"62","author":"A Ahamad","year":"2005","unstructured":"Ahamad A, D\u2019Souza W, Salehpour M, Iyer R, Tucker SL, Jhingran A, Eifel PJ (2005) Intensity-modulated radiation therapy after hysterectomy: comparison with conventional treatment and sensitivity of the normal-tissue-sparing effect to margin size. Int J Radiat Oncol Biol Phys 62:1117\u20131124. https:\/\/doi.org\/10.1016\/j.ijrobp.2004.12.029","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1844_CR27","doi-asserted-by":"publisher","first-page":"20170398","DOI":"10.1259\/bjr.20170398","volume":"91","author":"HC Luo","year":"2018","unstructured":"Luo HC, Lin GS, Liao SG, Wang FM, Cheng HH, Feng J, Yin Q, Chen QH, Zhu JF, Xu JF et al (2018) Cervical cancer treated with reduced-volume intensity-modulated radiation therapy base on Sedlis criteria (NCCN VS RTOG). Br J Radiol 91:20170398. https:\/\/doi.org\/10.1259\/bjr.20170398","journal-title":"Br J Radiol"},{"key":"1844_CR28","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.ejmp.2012.11.002","volume":"29","author":"G Yavas","year":"2013","unstructured":"Yavas G, Yavas C, Acar H, Buyukyoruk A, Cobanoglu G, Kerimoglu OS, Yavas O, Celik C (2013) Dosimetric comparison of 3-dimensional conformal and field-in-field radiotherapy techniques for the adjuvant treatment of early stage endometrial cancer. Phys Med 29:577\u2013582. https:\/\/doi.org\/10.1016\/j.ejmp.2012.11.002","journal-title":"Phys Med"},{"key":"1844_CR29","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s00066-017-1224-8y","volume":"194","author":"P de Boer","year":"2018","unstructured":"de Boer P, van de Schoot AJAJ, Westerveld H, Smit M, Buist MR, Bel A, Rasch CRN, Stalpers LJA (2018) Target tailoring and proton beam therapy to reduce small bowel dose in cervical cancer radiotherapy: a comparison of benefits. Strahlentherapie und Onkol. Organ der Dtsch 194:255\u2013263. https:\/\/doi.org\/10.1007\/s00066-017-1224-8y","journal-title":"Organ der Dtsch"},{"key":"1844_CR30","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1080\/0284186X.2016.1205218","volume":"55","author":"V Verma","year":"2016","unstructured":"Verma V, Simone CB 2nd, Wahl AO, Beriwal S, Mehta MP (2016) Proton radiotherapy for gynecologic neoplasms. Acta Oncol 55:1257\u20131265. https:\/\/doi.org\/10.1080\/0284186X.2016.1205218","journal-title":"Acta Oncol"},{"key":"1844_CR31","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.canrad.2016.06.007","volume":"20","author":"E Jouglar","year":"2016","unstructured":"Jouglar E, Thomas L, de la Rochefordi\u00e8re A, No\u00ebl G, Le Blanc-Onfroy M, Delpon G, Campion L, Mah\u00e9 MA (2016) Toxicity and early clinical outcomes in cervical cancer patients following extended field helical tomotherapyto para-aortic lymph nodes. Cancer Radiother 20:794\u2013800. https:\/\/doi.org\/10.1016\/j.canrad.2016.06.007","journal-title":"Cancer Radiother"},{"key":"1844_CR32","first-page":"643","volume":"29","author":"M Saynak","year":"2008","unstructured":"Saynak M, Kucucuk S, Aslay I (2008) Abdominal pillow for the sparing of small bowel in four-field conventional pelvic radiotherapy. Eur J Gynaecol Oncol 29:643\u2013648","journal-title":"Eur J Gynaecol Oncol"},{"key":"1844_CR33","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.ijrobp.2006.08.067","volume":"67","author":"S Beriwal","year":"2007","unstructured":"Beriwal S, Jain SK, Heron DE, de Andrade RS, Lin CJ, Kim H (2007) Dosimetric and toxicity comparison between prone and supine position IMRT for endometrial cancer. Int J Radiat Oncol Biol Phys 67:485\u2013489. https:\/\/doi.org\/10.1016\/j.ijrobp.2006.08.067","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1844_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/1748-717X-5-63","author":"C Stromberger","year":"2010","unstructured":"Stromberger C, Kom Y, Kawgan-Kagan M, Mensing T, Jahn U, Schneider A, Budach V, K\u00f6hler C, Marnitz S (2010) Intensity-modulated radiotherapy in patients with cervical cancer. An intra-individual comparison of prone and supine positioning. Radiation Oncology. https:\/\/doi.org\/10.1186\/1748-717X-5-63","journal-title":"Radiation Oncology"},{"key":"1844_CR35","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.radonc.2004.11.010","volume":"74","author":"J Martin","year":"2005","unstructured":"Martin J, Fitzpatrick K, Horan G, McCloy R, Buckney S, O\u2019Neill L, Faul C (2005) Treatment with a belly-board device significantly reduces the volume of small bowel irradiated and results in low acute toxicity in adjuvant radiotherapy for gynecologic cancer: results of a prospective study. Radiother Oncol J Eur Soc Ther Radiol Oncol 74:267\u2013274. https:\/\/doi.org\/10.1016\/j.radonc.2004.11.010","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol"},{"key":"1844_CR36","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1111\/1754-9485.12863","volume":"63","author":"A Hoover","year":"2019","unstructured":"Hoover A, Gunan Ganju R, TenNapel M, Chen A (2019) Visceral adipose ratio as a novel predictor for acute bowel toxicity in patients receiving pelvic radiation: Preliminary dosimetric analysis and clinical validation. J Med Imaging Radiat Oncol 63:408\u2013414. https:\/\/doi.org\/10.1111\/1754-9485.12863","journal-title":"J Med Imaging Radiat Oncol"},{"key":"1844_CR37","doi-asserted-by":"publisher","first-page":"10937","DOI":"10.4238\/2015.September.21.4","volume":"14","author":"S Xin","year":"2015","unstructured":"Xin S (2015) Setup errors in cone-beam computed tomography and their effects on acute radiation toxicity in cervical cancer radiotherapy. Genet Mol Res 14:10937\u201310943. https:\/\/doi.org\/10.4238\/2015.September.21.4","journal-title":"Genet Mol Res"},{"key":"1844_CR38","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.ygyno.2005.07.018","volume":"99","author":"W Park","year":"2005","unstructured":"Park W, Huh SJ, Lee JE, Han Y, Shin E, Ahn YC, Lim DH (2005) Variation of small bowel sparing with small bowel displacement system according to the physiological status of the bladder during radiotherapy for cervical cancer. Gynecol Oncol 99:645\u2013651. https:\/\/doi.org\/10.1016\/j.ygyno.2005.07.018","journal-title":"Gynecol Oncol"},{"key":"1844_CR39","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.radonc.2012.04.018","volume":"103","author":"LH Barraclough","year":"2012","unstructured":"Barraclough LH, Routledge JA, Farnell DJJ, Burns MP, Swindell R, Livsey JE, Davidson SE (2012) Prospective analysis of patient-reported late toxicity following pelvic radiotherapy for gynaecological cancer. Radiother Oncol J Eur Soc Ther Radiol Oncol 103:327\u2013332. https:\/\/doi.org\/10.1016\/j.radonc.2012.04.018","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol"},{"issue":"26","key":"1844_CR40","doi-asserted-by":"publisher","first-page":"3610","DOI":"10.3748\/wjg.v13.i26.3610","volume":"13","author":"A Larsen","year":"2007","unstructured":"Larsen A, Reitan JB, Aase ST, Hauer-Jensen M (2007) Long-term prognosis in patients with severe late radiation enteropathy: a prospective cohort study. World J Gastroenterol 13(26):3610\u20133613","journal-title":"World J Gastroenterol"},{"key":"1844_CR41","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1007\/s00384-015-2289-4","volume":"30","author":"BGL Vanneste","year":"2015","unstructured":"Vanneste BGL, Van De Voorde L, de Ridder RJ et al (2015) Chronic radiation proctitis: tricks to prevent and treat. Int J Colorectal Dis 30:1293\u20131303. https:\/\/doi.org\/10.1007\/s00384-015-2289-4","journal-title":"Int J Colorectal Dis"},{"key":"1844_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2011\/917941","volume":"2011","author":"NL Do","year":"2011","unstructured":"Do NL, Nagle D, Poylin VY (2011) Radiation proctitis: current strategies in management. Gastroenterol Res Pract 2011:1\u20139. https:\/\/doi.org\/10.1155\/2011\/917941","journal-title":"Gastroenterol Res Pract"},{"key":"1844_CR43","doi-asserted-by":"publisher","first-page":"22","DOI":"10.5946\/ce.2020.288","volume":"55","author":"DS Dahiya","year":"2022","unstructured":"Dahiya DS, Kichloo A, Tuma F, Albosta M, Wani F (2022) Radiation proctitis and management strategies. Clin Endosc 55:22\u201332. https:\/\/doi.org\/10.5946\/ce.2020.288","journal-title":"Clin Endosc"},{"issue":"1","key":"1844_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4292\/wjgpt.v6.i1.1","volume":"6","author":"L Fuccio","year":"2015","unstructured":"Fuccio L, Frazzoni L, Guido A (2015) Prevention of pelvic radiation disease world. J Gastrointest Pharmacol Ther 6(1):1\u20139. https:\/\/doi.org\/10.4292\/wjgpt.v6.i1.1","journal-title":"J Gastrointest Pharmacol Ther"},{"key":"1844_CR45","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.clon.2007.07.008","volume":"19","author":"K Leiper","year":"2007","unstructured":"Leiper K, Morris AI (2007) Treatment of radiation proctitis. Clin Oncol 19:724\u2013729. https:\/\/doi.org\/10.1016\/j.clon.2007.07.008","journal-title":"Clin Oncol"},{"key":"1844_CR46","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3748\/wjg.v19.i2.185","volume":"19","author":"AK Shadad","year":"2013","unstructured":"Shadad AK, Sullivan FJ, Martin JD, Egan LJ (2013) Gastrointestinal radiation injury: symptoms, risk factors and mechanism. World J Gastroenterol 19:185\u2013198. https:\/\/doi.org\/10.3748\/wjg.v19.i2.185","journal-title":"World J Gastroenterol"},{"key":"1844_CR47","doi-asserted-by":"publisher","first-page":"2180","DOI":"10.1007\/s10620-018-5163-8","volume":"6","author":"L Tabaja","year":"2018","unstructured":"Tabaja L, Sidani SM (2018) Management of radiation proctitis. Dig Dis Sci 6:2180\u20132188. https:\/\/doi.org\/10.1007\/s10620-018-5163-8","journal-title":"Dig Dis Sci"},{"issue":"6","key":"1844_CR48","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1093\/jjco\/hyab047","volume":"51","author":"G Zhang","year":"2021","unstructured":"Zhang G, He F, Miao L et al (2021) Post-operative small pelvic intensity-modulated radiation therapy for early-stage cervical cancer with intermediate-risk factors: efficacy and toxicity. Jpn J Clin Oncol 51(6):905\u2013910. https:\/\/doi.org\/10.1093\/jjco\/hyab047","journal-title":"Jpn J Clin Oncol"},{"key":"1844_CR49","doi-asserted-by":"publisher","first-page":"e23","DOI":"10.1016\/j.ijrobp.2012.02.044","volume":"84","author":"A Jhingran","year":"2011","unstructured":"Jhingran A, Winter K, Portelance L, Miller B, Salehpour M, Gaur R, Souhami L, Small W Jr, Berk L, Gaffney D (2011) A phase II study of intensity modulated radiation therapy to the pelvis for post-operative patients with endometrial carcinoma: radiation therapy oncology group trial 0418. Int J Radiat Oncol Biol Phys 84:e23-28. https:\/\/doi.org\/10.1016\/j.ijrobp.2012.02.044","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1844_CR50","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.radonc.2014.01.018","volume":"11","author":"I Barillot","year":"2014","unstructured":"Barillot I, Tavernier E, Peignaux K, Williaume D, Nickers P, Leblanc-Onfroy M, Lerouge D (2014) Impact of postoperative intensity modulated radiotherapy on acute gastro-intestinal toxicity for patients with endometrial cancer: Results of the phase II RTCMIENDOMETRE French multicentre trial. Radiother Oncol 11:138\u2013143. https:\/\/doi.org\/10.1016\/j.radonc.2014.01.018","journal-title":"Radiother Oncol"},{"key":"1844_CR51","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1200\/JCO.19.02381","volume":"38","author":"AR Yeung","year":"2020","unstructured":"Yeung AR, Pugh SL, Klopp AH, Gil KM, Wenzel L, Westin SN, Gaffney DK, Small W Jr, Thompson S, Doncals DE, Cantuaria GHC, Yaremko BP, Chang A, Kundapur V, Mohan DS, Haas ML, Kim YB, Ferguson CL, Deshmukh S, Bruner DW, Kachnic LA (2020) Improvement in patient-reported outcomes with intensity-modulated radiotherapy (RT) compared with standard RT: a report from the NRG oncology RTOG 1203 study. J Clin Oncol 38:1685\u20131692. https:\/\/doi.org\/10.1200\/JCO.19.02381","journal-title":"J Clin Oncol"},{"key":"1844_CR52","doi-asserted-by":"publisher","first-page":"3682","DOI":"10.1200\/JCO.20.02530","volume":"39","author":"S Chopra","year":"2021","unstructured":"Chopra S, Gupta S, Kannan S, Dora T, Engineer R, Mangaj A, Maheshwari A, Shylasree TS, Ghosh J, Paul SN, Phurailatpam R, Charnalia M, Alone M, Swamidas J, Mahantshetty U, Deodhar K, Kerkar R, Shrivastava SK (2021) Late toxicity after adjuvant conventional radiation versus image-guided intensity-modulated radiotherapy for cervical cancer (PARCER): a randomized controlled trial. J Clin Oncol 39:3682\u20133692. https:\/\/doi.org\/10.1200\/JCO.20.02530","journal-title":"J Clin Oncol"},{"key":"1844_CR53","doi-asserted-by":"publisher","first-page":"131","DOI":"10.4103\/0973-1482.199451","volume":"13","author":"N Patni","year":"2017","unstructured":"Patni N, Burela N, Pasricha R, Goyal J, Soni TP, Kumar TS, Natarajan T (2017) Assessment of three-dimensional setup errors in image-guided pelvic radiotherapy for uterine and cervical cancer using kilovoltage cone-beam computed tomography and its effect on planning target volume margins. J Cancer Res Ther 13:131\u2013136","journal-title":"J Cancer Res Ther"},{"key":"1844_CR54","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s13014-015-0412-x","volume":"10","author":"L Yao","year":"2015","unstructured":"Yao L, Zhu L, Wang J, Liu L, Zhou S, Jiang S, Cao Q, Qu A, Tian S (2015) Positioning accuracy during VMAT of gynecologic malignancies and the resulting dosimetric impact by a 6-degree-of-freedom couch in combination with daily kilovoltage cone beam computed tomography. Radiat Oncol 10:104\u2013111. https:\/\/doi.org\/10.1186\/s13014-015-0412-x","journal-title":"Radiat Oncol"},{"key":"1844_CR55","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/1748-717X-8-110","volume":"8","author":"C Stromberger","year":"2013","unstructured":"Stromberger C, Gruen A, Wlodarczyk W et al (2013) Optimizing image guidance frequency and implications on margins for gynecologic malignancies. Radiation Oncology. 8:110\u2013116. https:\/\/doi.org\/10.1186\/1748-717X-8-110","journal-title":"Radiation Oncology."},{"key":"1844_CR56","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.rpor.2018.05.002","volume":"23","author":"I R\u00edos","year":"2018","unstructured":"R\u00edos I, V\u00e1squez I, Cuervo E, Garz\u00f3n \u00d3, Burbano J (2018) Problems and solutions in IGRT for cervical cancer. Rep Pract Oncol Radiother 23:517\u2013527. https:\/\/doi.org\/10.1016\/j.rpor.2018.05.002","journal-title":"Rep Pract Oncol Radiother"},{"key":"1844_CR57","doi-asserted-by":"publisher","first-page":"10937","DOI":"10.4238\/2015.September.21.4","volume":"14","author":"S Xin","year":"2015","unstructured":"Xin S (2015) Setup errors in cone-beam computed tomography and their effects on acute radiation toxicity in cervical cancer radiotherapy. Genet Mol Res 14:10937\u201310943. https:\/\/doi.org\/10.4238\/2015.September.21.4","journal-title":"Genet Mol Res"},{"key":"1844_CR58","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1634\/theoncologist.12-6-738","volume":"12","author":"JR Kouvaris","year":"2007","unstructured":"Kouvaris JR, Kouloulias VE, Vlahos LJ (2007) Amifostine: the first selective-target and broad-spectrum radioprotector. Oncologist 12:738\u2013747. https:\/\/doi.org\/10.1634\/theoncologist.12-6-738","journal-title":"Oncologist"},{"key":"1844_CR59","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1080\/14740338.2019.1666104","volume":"18","author":"VK Singh","year":"2019","unstructured":"Singh VK, Seed TM (2019) The efficacy and safety of amifostine for the acute radiation syndrome. Expert Opin Drug Saf 18:1077\u20131090. https:\/\/doi.org\/10.1080\/14740338.2019.1666104","journal-title":"Expert Opin Drug Saf"},{"key":"1844_CR60","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/1756-9966-29-68","volume":"29","author":"KH Katsanos","year":"2010","unstructured":"Katsanos KH et al (2010) Randomized phase II exploratory study of prophylactic amifostine in cancer patients who receive radical radiotherapy to the pelvis. J Exp Clin Cancer Res 29:68\u201376","journal-title":"J Exp Clin Cancer Res"},{"key":"1844_CR61","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.ijrobp.2004.10.043","volume":"62","author":"VE Kouloulias","year":"2005","unstructured":"Kouloulias VE, Kouvaris JR, Pissakas G, Mallas E, Antypas C, Kokakis JD, Matsopoulos G, Michopoulos S, Mystakidou K, Vlahos LJ (2005) Phase II multicenter randomized study of amifostine for prevention of acute radiation rectal toxicity: topical intrarectal versus subcutaneous application. Int J Radiat Oncol Biol Phys 62:486\u2013493. https:\/\/doi.org\/10.1016\/j.ijrobp.2004.10.043","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1844_CR62","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1159\/000502979","volume":"98","author":"M King","year":"2020","unstructured":"King M, Joseph S, Albert A, Thomas TV, Nittala MR, Woods WC, Vijayakumar S, Packianathan S (2020) Use of Amifostine for cytoprotection during radiation therapy: a review. Oncology 98:61\u201380. https:\/\/doi.org\/10.1159\/000502979","journal-title":"Oncology"},{"key":"1844_CR63","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s00520-012-1644-z","volume":"21","author":"RJ Gibson","year":"2013","unstructured":"Gibson RJ, Keefe DM, Lalla RV, Bateman E, Blijlevens N, Fijlstra M, King EE, Stringer AM, van der Velden WJ, Yazbeck R, Elad S, Bowen JM (2013) For the mucositis study group of the multinational association of supportive care in cancer\/international society of oral oncology (MASCC\/ISOO). systematic review of agents for the management of gastrointestinal mucositis in cancer patients. Support Care Cancer 21:313\u2013326. https:\/\/doi.org\/10.1007\/s00520-012-1644-z","journal-title":"Support Care Cancer"},{"key":"1844_CR64","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1136\/gutjnl-2011-301704","volume":"61","author":"L Fuccio","year":"2012","unstructured":"Fuccio L, Guido A (2012) Topical rectal beclomethasone dipropionate treatment for the prevention of radiation-induced bleeding. Gut 61:1369. https:\/\/doi.org\/10.1136\/gutjnl-2011-301704","journal-title":"Gut"},{"key":"1844_CR65","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/ajco.12289","volume":"11","author":"AR Tahir","year":"2015","unstructured":"Tahir AR, Westhuyzen J, Dass J, Collins MK, Webb R, Hewitt S, Fon P, McKay M (2015) Hyperbaric oxygen therapy for chronic radiation-induced tissue injuries: Australasia\u2019s largest study. Asia Pac J Clin Oncol 11:68\u201377. https:\/\/doi.org\/10.1111\/ajco.12289","journal-title":"Asia Pac J Clin Oncol"},{"key":"1844_CR66","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.clon.2007.12.005","volume":"20","author":"T Safra","year":"2008","unstructured":"Safra T, Gutman G, Fishlev G, Soyfer V, Gall N, Lessing JB, Almog R, Matcievsky D, Grisaru D (2008) Improved quality of life with hyperbaric oxygen therapy in patients with persistent pelvic radiation-induced toxicity. Clinical Oncol 20:284\u2013287. https:\/\/doi.org\/10.1016\/j.clon.2007.12.005","journal-title":"Clinical Oncol"},{"key":"1844_CR67","first-page":"169","volume":"39","author":"S Sidik","year":"2007","unstructured":"Sidik S, Hardjodisastro D, Setiabudy R, Gondowiardjo S (2007) Does hyperbaric oxygen administration decrease side effect and improve quality of life after pelvic radiation? Acta Med Indones 39:169\u2013173","journal-title":"Acta Med Indones"},{"key":"1844_CR68","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005005.pub5","author":"ZC Lin","year":"2023","unstructured":"Lin ZC, Bennett MH, Hawkins GC, Azzopardi CP, Feldmeier J, Smee R, Milross C (2023) Hyperbaric oxygen therapy for late radiation tissue injury. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD005005.pub5","journal-title":"Cochrane Database Syst Rev"},{"key":"1844_CR69","doi-asserted-by":"publisher","first-page":"4554","DOI":"10.3748\/wjg.v17.i41.4554","volume":"17","author":"T Rustagi","year":"2011","unstructured":"Rustagi T, Mashimo H (2011) Endoscopic management of chronic radiation proctitis. World J Gastroenterol 17:4554\u20134562. https:\/\/doi.org\/10.3748\/wjg.v17.i41.4554","journal-title":"World J Gastroenterol"},{"key":"1844_CR70","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1055\/s-0029-1214726","volume":"41","author":"G Karamanolis","year":"2009","unstructured":"Karamanolis G, Triantafyllou K, Tsiamoulos Z, Polymeros D, Kalli T, Misailidis N, Ladas SD (2009) Argon plasma coagulation has a long-lasting therapeutic effect in patients with chronic radiation proctitis. Endoscopy 41:529\u2013531. https:\/\/doi.org\/10.1055\/s-0029-1214726","journal-title":"Endoscopy"},{"key":"1844_CR71","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1177\/1756283X08103341","volume":"2","author":"C Zhou","year":"2009","unstructured":"Zhou C, Adler DC, Becker L, Chen Y, Tsai TH, Figueiredo M, Schmitt JM, Fujimoto JG, Mashimo H (2009) Effective treatment of chronic radiation proctitis using radiofrequency ablation. Therap Adv Gastroenterol 2:149\u2013156. https:\/\/doi.org\/10.1177\/1756283X08103341","journal-title":"Therap Adv Gastroenterol"},{"key":"1844_CR72","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.gie.2010.10.044","volume":"73","author":"JK Hou","year":"2011","unstructured":"Hou JK, Abudayyeh S, Shaib Y (2011) Treatment of chronic radiation proctitis with cryoablation. Gastrointest Endosc 73:383\u2013389. https:\/\/doi.org\/10.1016\/j.gie.2010.10.044","journal-title":"Gastrointest Endosc"},{"key":"1844_CR73","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1016\/j.ijrobp.2008.12.018","volume":"75","author":"SW Chen","year":"2009","unstructured":"Chen SW, Liang JA, Hung YC, Yeh LS, Chang WC, Yang SN, Lin FJ (2009) Geometrical sparing factors for the rectum and bladder in the prediction of grade 2 and higher complications after high-dose brachytherapy for cervical cancer. Int J Radiat Oncol Biol Phys 75:1335\u20131343. https:\/\/doi.org\/10.1016\/j.ijrobp.2008.12.018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1844_CR74","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.ygyno.2010.11.021","volume":"120","author":"G Macchia","year":"2011","unstructured":"Macchia G, Ferrandina G, Deodato F, Bibb\u00f2 R, Massaccesi M, Ippolito E, Cellini N, Scambia G, Valentini V, Morganti AG (2011) 3D conformal postoperative radiotherapy with concomitant boost in uterine cancer: results of a phase I-II study (ADA-RT-1). Gynecol Oncol 120:485\u2013488. https:\/\/doi.org\/10.1016\/j.ygyno.2010.11.021","journal-title":"Gynecol Oncol"},{"key":"1844_CR75","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.ygyno.2007.04.030","volume":"106","author":"KN Moore","year":"2007","unstructured":"Moore KN, Gold MA, McMeekin DS, Zorn KK (2007) Vesicovaginal fistula formation in patients with Stage IVA cervical carcinoma. Gynecol Oncol 106:498\u2013501. https:\/\/doi.org\/10.1016\/j.ygyno.2007.04.030","journal-title":"Gynecol Oncol"},{"key":"1844_CR76","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.ygyno.2010.10.017","volume":"120","author":"R Samper-Ternent","year":"2011","unstructured":"Samper-Ternent R, Zhang D, Kuo YF, Hatch S, Freeman J (2011) Late GI and bladder toxicities after radiation for uterine cancer. Gynecol Oncol 120:198\u2013204. https:\/\/doi.org\/10.1016\/j.ygyno.2010.10.017","journal-title":"Gynecol Oncol"},{"key":"1844_CR77","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.radonc.2020.10.003","volume":"158","author":"S Spampinato","year":"2021","unstructured":"Spampinato S, Fokdal LU, P\u00f6tter R, Haie-Meder C, Lindegaard JC, Schmid MP, Sturdza A, J\u00fcrgenliemk-Schulz IM, Mahantshetty U, Segedin B, Bruheim K, Hoskin P, Rai B, Huang F, Cooper R, van der Steen-Banasik E, Van Limbergen E, Sundset M, Westerveld H, Nout RA, Jensen NBK, Kirisits C, Kirchheiner K, Tanderup K (2021) EMBRACE collaborative group. importance of the ICRU bladder point dose on incidence and persistence of urinary frequency and incontinence in locally advanced cervical cancer: an EMBRACE analysis. Radiother Oncol 158:300\u2013308. https:\/\/doi.org\/10.1016\/j.radonc.2020.10.003","journal-title":"Radiother Oncol"},{"issue":"4","key":"1844_CR78","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/j.ijrobp.2018.11.006","volume":"103","author":"L Fokdal","year":"2019","unstructured":"Fokdal L, Tanderup K, P\u00f6tter R, Sturdza A, Kirchheiner K, Chargari C, J\u00fcrgenliemk-Schulz IM, Segedin B, Tan LT, Hoskin P, Mahantshetty U (2019) Risk factors for ureteral stricture after radiochemotherapy including image guided adaptive brachytherapy in cervical cancer: results from the EMBRACE studies. Int J Radiat Oncol Bio Phys 103(4):887\u201394","journal-title":"Int J Radiat Oncol Bio Phys"},{"issue":"5","key":"1844_CR79","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1016\/j.ijrobp.2006.11.005","volume":"67","author":"MF Chen","year":"2007","unstructured":"Chen MF, Tseng CJ, Tseng CC, Kuo YC, Yu CY, Chen WC (2007) Clinical outcome in posthysterectomy cervical cancer patients treated with concurrent Cisplatin and intensity-modulated pelvic radiotherapy: comparison with conventional radiotherapy. Int J Radiat Oncol Bio Phys 67(5):1438\u20131444","journal-title":"Int J Radiat Oncol Bio Phys"},{"issue":"80","key":"1844_CR80","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1016\/j.ijrobp.2010.04.041","volume":"1","author":"MD Hasselle","year":"2011","unstructured":"Hasselle MD, Rose BS, Kochanski JD, Nath SK, Bafana R, Yashar CM, Hasan Y, Roeske JC, Mundt AJ, Mell LK (2011) Clinical outcomes of intensity-modulated pelvic radiation therapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys 1(80):1436\u20131445. https:\/\/doi.org\/10.1016\/j.ijrobp.2010.04.041","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1844_CR81","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1007\/s00066-021-01782-5","volume":"197","author":"LH Dr\u00f6ge","year":"2021","unstructured":"Dr\u00f6ge LH, von Sivers FF, Schirmer MA, Wolff HA (2021) Conventional 3D conformal radiotherapy and volumetric modulated arc therapy for cervical cancer: Comparison of clinical results with special consideration of the influence of patient- and treatment-related parameters. Strahlenther Onkol 197:520\u2013527. https:\/\/doi.org\/10.1007\/s00066-021-01782-5","journal-title":"Strahlenther Onkol"},{"key":"1844_CR82","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.brachy.2015.10.001","volume":"15","author":"MJ Amsbaugh","year":"2016","unstructured":"Amsbaugh MJ, Bhatt N, Hunter T, Gaskins J, Parker L, Metzinger D, Amsbaugh A, Sowards K, El-Ghamry MN (2016) Computed tomography-planned interstitial brachytherapy for locally advanced gynecologic cancer: outcomes and dosimetric predictors of urinary toxicity. Brachytherapy 15:49\u201356. https:\/\/doi.org\/10.1016\/j.brachy.2015.10.001","journal-title":"Brachytherapy"},{"issue":"101","key":"1844_CR83","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.ijrobp.2018.02.004","volume":"1","author":"E Manea","year":"2018","unstructured":"Manea E, Escande A, Bockel S, Khettab M, Dumas I, Lazarescu I, Fumagalli I, Morice P, Deutsch E, Haie-Meder C, Chargari C (2018) Risk of late urinary complications following image guided adaptive brachytherapy for locally advanced cervical cancer: refining bladder dose-volume parameters. Int J Radiat Oncol Biol Phys 1(101):411\u2013420. https:\/\/doi.org\/10.1016\/j.ijrobp.2018.02.004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1844_CR84","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1007\/s11255-018-1970-2","volume":"50","author":"BMM Zwaans","year":"2018","unstructured":"Zwaans BMM, Lamb LE, Bartolone S, Nicolai HE, Chancellor MB, Klaudia SW (2018) Cancer survivorship issues with radiation and hemorrhagic cystitis in gynecological malignancies. Int Urol Nephrol 50:1745\u20131751. https:\/\/doi.org\/10.1007\/s11255-018-1970-2","journal-title":"Int Urol Nephrol"},{"key":"1844_CR85","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.radonc.2018.05.002","volume":"127","author":"L Fokdal","year":"2018","unstructured":"Fokdal L, P\u00f6tter R, Kirchheiner K, Lindegaard JC, Jensen NBK, Kirisits C, Chargari C, Mahantshetty U, J\u00fcrgenliemk-Schulz IM, Segedin B, Hoskin P, Tanderup K (2018) Physician assessed and patient reported urinary morbidity after radio-chemotherapy and image guided adaptive brachytherapy for locally advanced cervical cancer. Radiother Oncol 127:423\u2013430. https:\/\/doi.org\/10.1016\/j.radonc.2018.05.002","journal-title":"Radiother Oncol"},{"key":"1844_CR86","doi-asserted-by":"publisher","first-page":"470","DOI":"10.5468\/ogs.20012","volume":"63","author":"JE Lee","year":"2020","unstructured":"Lee JE, Park CY, Lee E, Ji YI (2020) Effect of gynecological cancer and its treatment on bone mineral density and the risk of osteoporosis and osteoporotic fracture. Obstet Gynecol Sci 63:470\u2013479. https:\/\/doi.org\/10.5468\/ogs.20012","journal-title":"Obstet Gynecol Sci"},{"key":"1844_CR87","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.ygyno.2020.11.028","volume":"160","author":"JN Sobecki","year":"2021","unstructured":"Sobecki JN, Rice LW, Hartenbach EM (2021) Bone health and osteoporosis screening in gynecologic cancer survivors. Gynecol Oncol 160:619\u2013624. https:\/\/doi.org\/10.1016\/j.ygyno.2020.11.028","journal-title":"Gynecol Oncol"},{"key":"1844_CR88","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1634\/theoncologist.2012-0416","volume":"18","author":"C Stavraka","year":"2013","unstructured":"Stavraka C, Maclaran K, Gabra H, Agarwal R, Ghaemi-Maghami S, Taylor A, Dhillo WS, Panay N, Blagden SP (2013) A study to evaluate the cause of bone demineralization in gynecological cancer survivors. TheOncologist 18:423\u2013429. https:\/\/doi.org\/10.1634\/theoncologist.2012-0416","journal-title":"TheOncologist"},{"key":"1844_CR89","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.clon.2015.07.006","volume":"27","author":"CE Higham","year":"2015","unstructured":"Higham CE, Faithfull S (2015) Bone health and pelvic radiotherapy. Clin Oncol (R Coll Radiol) 27:668\u2013678. https:\/\/doi.org\/10.1016\/j.clon.2015.07.006","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"1844_CR90","doi-asserted-by":"publisher","first-page":"e398","DOI":"10.1111\/ajco.12584","volume":"12","author":"SW Lee","year":"2016","unstructured":"Lee SW, Yeo SG, Oh IH, Yeo JH, Park DC (2016) Bone mineral density in women treated for various types of gynecological cancer. Asia Pac J Clin Oncol 12:e398\u2013e404. https:\/\/doi.org\/10.1111\/ajco.12584","journal-title":"Asia Pac J Clin Oncol"},{"key":"1844_CR91","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00587","author":"S Costa","year":"2019","unstructured":"Costa S, Reagan MR (2019) Therapeutic Irradiation: consequences for bone and bone marrow adipose tissue. Front Endocrinol (Lausanne). https:\/\/doi.org\/10.3389\/fendo.2019.00587","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1844_CR92","doi-asserted-by":"publisher","first-page":"213","DOI":"10.3857\/roj.2014.32.4.213","volume":"32","author":"D Oh","year":"2014","unstructured":"Oh D, Huh SJ (2014) Insufficiency fracture after radiation therapy. Radiat Oncol J 32:213\u2013220. https:\/\/doi.org\/10.3857\/roj.2014.32.4.213","journal-title":"Radiat Oncol J"},{"issue":"126","key":"1844_CR93","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.1002\/cncr.32807","volume":"1","author":"MP Salcedo","year":"2020","unstructured":"Salcedo MP, Sood AK, Jhingran A, Eifel PJ, Klopp AH, Iyer RB, Fellman BM, Jimenez C, Schmeler KM (2020) Pelvic fractures and changes in bone mineral density after radiotherapy for cervical, endometrial, and vaginal cancer: a prospective study of 239 women. Cancer 1(126):2607\u20132613. https:\/\/doi.org\/10.1002\/cncr.32807","journal-title":"Cancer"},{"key":"1844_CR94","doi-asserted-by":"publisher","first-page":"21","DOI":"10.21037\/qims-20-553","volume":"11","author":"H Malikova","year":"2021","unstructured":"Malikova H, Burghardtova M, Fejfarova K, Nadova K, Weichet J (2021) Advanced cervical cancer in young women: imaging study of late and very late radiation-related side effects after successful treatment by combined radiotherapy. Quant Imaging Med Surg. 11:21\u201331. https:\/\/doi.org\/10.21037\/qims-20-553","journal-title":"Quant Imaging Med Surg."},{"issue":"97","key":"1844_CR95","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1016\/j.ijrobp.2017.01.026","volume":"1","author":"A Ramlov","year":"2017","unstructured":"Ramlov A, Morre Pedersen E, R\u00f8hl L, Worm E, Fokdal L, Lindegaard JC, Tanderup K (2017) Risk factors for pelvic insufficiency fractures in locally advanced cervical cancer following intensity modulated radiation therapy. Int J Radiat Oncol Biol Phys 1(97):1032\u20131039. https:\/\/doi.org\/10.1016\/j.ijrobp.2017.01.026","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1844_CR96","doi-asserted-by":"publisher","first-page":"20160885","DOI":"10.1259\/bjr.20160885","volume":"90","author":"L Bazire","year":"2017","unstructured":"Bazire L, Xu H, Foy JP, Amessis M, Malhaire C, Cao K, De La Rochefordiere A, Kirova YM (2017) Pelvic insufficiency fracture (PIF) incidence in patients treated with intensity-modulated radiation therapy (IMRT) for gynaecological or anal cancer: single-institution experience and review of the literature. Br J Radiol 90:20160885. https:\/\/doi.org\/10.1259\/bjr.20160885","journal-title":"Br J Radiol"},{"key":"1844_CR97","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.ijrobp.2019.09.012","volume":"106","author":"LG Sapienza","year":"2020","unstructured":"Sapienza LG, Salcedo MP, Ning MS, Jhingran A, Klopp AH, Calsavara VF, Schmeler KM, Leite Gomes MJ, de Freitas CE, Baiocchi G (2020) Pelvic insufficiency fractures after external beam radiation therapy for gynecologic cancers: a meta-analysis and meta-regression of 3929 patients. Int J Radiat Oncol Biol Phys 106:475\u2013484. https:\/\/doi.org\/10.1016\/j.ijrobp.2019.09.012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1844_CR98","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.21873\/invivo.12356","volume":"35","author":"YK Chung","year":"2021","unstructured":"Chung YK, Lee YK, Yoon BH, Suh DH, Koo KH (2021) Pelvic Insufficiency Fractures in Cervical\u00a0Cancer\u00a0After Radiation Therapy: A Meta-Analysis and Review. In Vivo 35:1109\u20131115. https:\/\/doi.org\/10.21873\/invivo.12356","journal-title":"In Vivo"},{"key":"1844_CR99","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.ijrobp.2020.05.013","volume":"108","author":"N Razavian","year":"2020","unstructured":"Razavian N, Laucis A, Sun Y, Spratt DE, Owen D, Schonewolf C, Uppal S, Maturen KE, Jolly S (2020) Radiation-induced insufficiency fractures after pelvic irradiation for gynecologic malignancies: a systematic review. Int J Radiat Oncol Biol Phys 108:620\u2013634. https:\/\/doi.org\/10.1016\/j.ijrobp.2020.05.013","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"106","key":"1844_CR100","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.ijrobp.2019.10.006","volume":"1","author":"LK Vitzthum","year":"2020","unstructured":"Vitzthum LK, Park H, Zakeri K, Heide ES, Nalawade V, Mundt AJ, Vaida F, Murphy JD, Mell LK (2020) Risk of pelvic fracture with radiation therapy in older patients. Int J Radiat Oncol Biol Phys 1(106):485\u2013492. https:\/\/doi.org\/10.1016\/j.ijrobp.2019.10.006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1844_CR101","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1002\/cncr.24811","volume":"116","author":"KM Schmeler","year":"2010","unstructured":"Schmeler KM, Jhingran A, Iyer RB, Sun CC, Eifel PJ, Soliman PT, Ramirez PT, Frumovitz M, Bodurka DC, Sood AK (2010) Pelvic fractures after radiotherapy for cervical cancer: implications for survivors. Cancer 116:625\u2013630. https:\/\/doi.org\/10.1002\/cncr.24811","journal-title":"Cancer"},{"key":"1844_CR102","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1016\/j.ijrobp.2007.08.005","volume":"70","author":"D Oh","year":"2008","unstructured":"Oh D, Huh SJ, Nam H, Park W, Han Y, Lim DH, Ahn YC, Lee JW, Kim BG, Bae DS, Lee JH (2008) Pelvic insufficiency fracture after pelvic radiotherapy for cervical cancer: analysis of risk factors. Int J Radiat Oncol Biol Phys 70:1183\u20131188. https:\/\/doi.org\/10.1016\/j.ijrobp.2007.08.005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1844_CR103","doi-asserted-by":"publisher","first-page":"e101","DOI":"10.1016\/j.clon.2020.10.013","volume":"33","author":"R Mir","year":"2021","unstructured":"Mir R, Dragan AD, Mistry HB, Tsang YM, Padhani AR, Hoskin P (2021) Sacral insufficiency fracture following pelvic radiotherapy in gynaecological malignancies: development of a predictive model. Clin Oncol (R Coll Radiol) 33:e101\u2013e109. https:\/\/doi.org\/10.1016\/j.clon.2020.10.013","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"1844_CR104","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s11604-020-01039-8","volume":"39","author":"K Ishikawa","year":"2021","unstructured":"Ishikawa K, Yamashiro T, Ariga T, Toita T, Kudaka W, Heianna J, Maemoto H, Kusada T, Makino W, Aoki Y, Murayama S (2021) Predictive factors of posttreatment fracture by definitive radiotherapy for uterine cervical cancer. Jpn J Radiol. 39:93\u201399. https:\/\/doi.org\/10.1007\/s11604-020-01039-8","journal-title":"Jpn J Radiol."},{"key":"1844_CR105","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s00066-020-01690-0","volume":"197","author":"D Kurrumeli","year":"2021","unstructured":"Kurrumeli D, Oechsner M, Weidenb\u00e4cher B, Brambs C, L\u00f6ffler M, Combs SE, Borm K, Duma MN (2021) An easy way to determine bone mineral density and predict pelvic insufficiency fractures in patients treated with radiotherapy for cervical cancer. Strahlenther Onkol 197:487\u2013493. https:\/\/doi.org\/10.1007\/s00066-020-01690-0","journal-title":"Strahlenther Onkol"},{"key":"1844_CR106","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/j.ygyno.2006.06.038","volume":"103","author":"H Ikushima","year":"2006","unstructured":"Ikushima H, Osaki K, Furutani S, Yamashita K, Kishida Y, Kudoh T, Nishitani H (2006) Pelvic bone complications following radiation therapy of gynecologic malignancies: clinical evaluation of radiation-induced pelvic insufficiency fractures. Gynecol Oncol 103:1100\u20131104. https:\/\/doi.org\/10.1016\/j.ygyno.2006.06.038","journal-title":"Gynecol Oncol"},{"key":"1844_CR107","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1093\/jrr\/rrt055","volume":"54","author":"H Uezono","year":"2013","unstructured":"Uezono H, Tsujino K, Moriki K, Nagano F, Ota Y, Sasaki R, Soejima T (2013) Pelvic insufficiency fracture after definitive radiotherapy for uterine cervical cancer: retrospective analysis of risk factors. J Radiat Res 54:1102\u20131109. https:\/\/doi.org\/10.1093\/jrr\/rrt055","journal-title":"J Radiat Res"},{"key":"1844_CR108","doi-asserted-by":"publisher","first-page":"e195","DOI":"10.1016\/j.ijrobp.2012.03.042","volume":"84","author":"S Tokumaru","year":"2012","unstructured":"Tokumaru S, Toita T, Oguchi M, Ohno T, Kato S, Niibe Y, Kazumoto T, Kodaira T, Kataoka M, Shikama N, Kenjo M, Yamauchi C, Suzuki O, Sakurai H, Teshima T, Kagami Y, Nakano T, Hiraoka M, Mitsuhashi N, Kudo S (2012) Insufficiency fractures after pelvic radiation therapy for uterine cervical cancer: an analysis of subjects in a prospective multi-institutional trial, and cooperative study of the Japan Radiation Oncology Group (JAROG) and Japanese Radiation Oncology Study Group (JROSG). Int J Radiat Oncol Biol Phys 84:e195-200. https:\/\/doi.org\/10.1016\/j.ijrobp.2012.03.042","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1844_CR109","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.ygyno.2012.12.021","volume":"128","author":"KK Shih","year":"2013","unstructured":"Shih KK, Folkert MR, Kollmeier MA, Abu-Rustum NR, Sonoda Y, Leitao MM Jr, Barakat RR, Alektiar KM (2013) Pelvic insufficiency fractures in patients with cervical and endometrial cancer treated with postoperative pelvic radiation. Gynecol Oncol 128:540\u2013543. https:\/\/doi.org\/10.1016\/j.ygyno.2012.12.021","journal-title":"Gynecol Oncol"},{"key":"1844_CR110","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.ygyno.2017.09.035","volume":"147","author":"K Yamamoto","year":"2017","unstructured":"Yamamoto K, Nagao S, Suzuki K, Kogiku A, Senda T, Yano H, Kitai M, Shiozaki T, Matsuoka K, Yamaguchi S (2017) Pelvic fractures after definitive and postoperative radiotherapy for cervical cancer: a retrospective analysis of risk factors. Gynecol Oncol 147:585\u2013588. https:\/\/doi.org\/10.1016\/j.ygyno.2017.09.035","journal-title":"Gynecol Oncol"},{"key":"1844_CR111","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/ecc.12105","volume":"23","author":"Q Mehmood","year":"2014","unstructured":"Mehmood Q, Beardwood M, Swindell R, Greenhalgh S, Wareham T, Barraclough L, Livsey J, Davidson SE (2014) Insufficiency fractures in patients treated with pelvic radiotherapy and chemotherapy for uterine and cervical cancer. Eur J Cancer Care (Engl) 23:43\u201350. https:\/\/doi.org\/10.1111\/ecc.12105","journal-title":"Eur J Cancer Care (Engl)"},{"key":"1844_CR112","doi-asserted-by":"publisher","first-page":"e423","DOI":"10.1016\/j.prro.2022.03.013","volume":"12","author":"J Wu","year":"2022","unstructured":"Wu J, Lakomy DS, Fellman BM, Salcedo MP, Sood AK, Jhingran A, Klopp AH, Iyer RB, Jimenez C, Colbert LE, Eifel PJ, Schmeler KM, Lin LL (2022) Longitudinal changes in bone mineral measurements inside and outside radiation fiels used for cervical cancer treatment. Pract Radiat Oncol 12:e423\u2013e433. https:\/\/doi.org\/10.1016\/j.prro.2022.03.013","journal-title":"Pract Radiat Oncol"},{"key":"1844_CR113","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.maturitas.2020.01.005","volume":"30","author":"M Rees","year":"2020","unstructured":"Rees M, Angioli R, Coleman RL, Glasspool RM, Plotti F, Simoncini T, Terranova C (2020) European Menopause and Andropause Society (EMAS) and International Gynecologic Cancer Society (IGCS) position statement on managing the menopause after gynecological cancer: focus on menopausal symptoms and osteoporosis. Int J Gynecol Cancer 30:428\u2013433. https:\/\/doi.org\/10.1016\/j.maturitas.2020.01.005","journal-title":"Int J Gynecol Cancer"},{"key":"1844_CR114","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.ijrobp.2022.07.1833","volume":"115","author":"M Harkenrider","year":"2023","unstructured":"Harkenrider M, Fields E, Chopra S, Damast S, Kidd EA, Junzo CJ (2023) Recent key studies in cancers of the uterine corpus and cervix: new updates in immunotherapy, the microbiome, bone density, quantifying lymphovascular invasion, and hypofractionated pelvic radiation therapy. Int J Radiation Oncol Biol Phys 115:269\u2013275. https:\/\/doi.org\/10.1016\/j.ijrobp.2022.07.1833","journal-title":"Int J Radiation Oncol Biol Phys"},{"key":"1844_CR115","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1097\/IGC.0000000000000117","volume":"24","author":"YJ Ioffe","year":"2014","unstructured":"Ioffe YJ, Hillen TJ, Zhou G, Schwarz JK, Massad LS, Powell MA, Hagemann AR, Mutch DG, Thaker PH (2014) Postradiation damage to the pelvic girdle in cervical cancer patients: is intensity-modulated radiation therapy safer than conventional radiation? Int J Gynecol Cancer 24:806\u2013812. https:\/\/doi.org\/10.1097\/IGC.0000000000000117","journal-title":"Int J Gynecol Cancer"},{"key":"1844_CR116","doi-asserted-by":"publisher","first-page":"174550652110707","DOI":"10.1177\/17455065211070747","volume":"18","author":"CA O\u2019Gorman","year":"2022","unstructured":"O\u2019Gorman CA, Minnock S, Mulhall J, Gleeson N (2022) Attention to bone health in follow-up of\u00a0gynaecological\u00a0cancers in tertiary care. Women\u2019s Health 18:17455065211070748. https:\/\/doi.org\/10.1177\/17455065211070747","journal-title":"Women's Health"},{"key":"1844_CR117","doi-asserted-by":"publisher","first-page":"987","DOI":"10.2214\/AJR.07.3634","volume":"191","author":"JW Kwon","year":"2008","unstructured":"Kwon JW, Huh SJ, Yoon YC, Choi SH, Jung JY, Oh D, Choe BK (2008) Pelvic bone complications after radiation therapy of uterine cervical cancer: evaluation with MRI. AJR Am J Roentgenol 191:987\u2013994. https:\/\/doi.org\/10.2214\/AJR.07.3634","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"1844_CR118","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/s12905-022-01758-2","volume":"22","author":"X Zhong","year":"2022","unstructured":"Zhong X, Zhang L, Dong T, Mai H, Lu B, Huang L, Li J (2022) Clinical and MRI features of sacral insufficiency fractures after radiotherapy in patients with cervical cancer. BMC Women\u2019s Health 22(1):166. https:\/\/doi.org\/10.1186\/s12905-022-01758-2","journal-title":"BMC Women's Health"},{"key":"1844_CR119","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/j.ijrobp.2009.12.025","volume":"79","author":"K Albuquerque","year":"2011","unstructured":"Albuquerque K, Giangreco D, Morrison C, Siddiqui M, Sinacore J, Potkul R, Roeske J (2011) Radiation-related predictors of hematologic toxicity after concurrent chemoradiation for cervical cancer and implications for bone marrow\u2013 sparing pelvic IMRT. Int J Radiat Oncol Biol Phys 79:1043\u20131047. https:\/\/doi.org\/10.1016\/j.ijrobp.2009.12.025","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1844_CR120","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.prro.2017.07.001","volume":"8","author":"K Yan","year":"2018","unstructured":"Yan K, Ramirez E, Xie X-J, Gu X, Xi Y, Albuquerque K (2018) Predicting severe hematologic toxicity from extended-field chemoradiation of para-aortic nodal metastases from cervical cancer. Pract Radiat Oncol 8:13\u20139. https:\/\/doi.org\/10.1016\/j.prro.2017.07.001","journal-title":"Pract Radiat Oncol"},{"key":"1844_CR121","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/j.ijrobp.2013.09.017","volume":"87","author":"JG Bazan","year":"2013","unstructured":"Bazan JG, Luxton G, Kozak MM, Anderson EM, Hancock SL, Kapp DS, Kidd EA, Koong AC, Chang DT (2013) Impact of chemotherapy on normal tissue complication probability models of acute hematologic toxicity in patients receiving pelvic intensity modulated radiation therapy. Int J Radiat Oncol Biol Phys 87:983\u2013991. https:\/\/doi.org\/10.1016\/j.ijrobp.2013.09.017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1844_CR122","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1016\/j.ijrobp.2011.09.048","volume":"83","author":"BS Rose","year":"2012","unstructured":"Rose BS, Liang Y, Lau SK, Jensen LG, Yashar CM, Hoh CK, Mell LK (2012) Correlation between radiation dose to 1\u2078F-FDG-PET defined active bone marrow subregions and acute hematologic toxicity in cervical cancer patients treated with chemoradiotherapy. Int J Radiat Oncol Biol Phys 83:1185\u20131191. https:\/\/doi.org\/10.1016\/j.ijrobp.2011.09.048","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1844_CR123","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s12094-016-1504-2","volume":"19","author":"P Franco","year":"2016","unstructured":"Franco P, Ragona R, Arcadipane F, Mistrangelo M, Cassoni P, Rondi N, Morino M, Racca P, Ricardi U (2016) Dosimetric predictors of acute hematologic toxicity during concurrent intensity-modulated radiotherapy and chemotherapy for anal cancer. Clin Transl Oncol 19:67\u201375. https:\/\/doi.org\/10.1007\/s12094-016-1504-2","journal-title":"Clin Transl Oncol"},{"key":"1844_CR124","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1016\/j.ijrobp.2006.03.018","volume":"66","author":"LK Mell","year":"2006","unstructured":"Mell LK, Kochanski JD, Roeske JC, Haslam JJ, Mehta N, Yamada SD, Hurteau JA, Collins YC, Lengyel E, Mundt AJ (2006) Dosimetric predictors of acute hematologic toxicity in cervical cancer patients treated with concurrent cisplatin and intensity-modulated pelvic radiotherapy. Int J Radiat Oncol Biol Phys 66:1356\u20131365. https:\/\/doi.org\/10.1016\/j.ijrobp.2006.03.018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1844_CR125","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/j.ijrobp.2009.11.010","volume":"79","author":"BS Rose","year":"2011","unstructured":"Rose BS, Aydogan B, Liang Y, Yeginer M, Hasselle MD, Dandekar V, Bafana R, Yashar CM, Mundt AJ, Roeske JC, Mell LK (2011) Normal tissue complication probability modeling of acute hematologic toxicity in cervical cancer patients treated with chemoradiotherapy. Int J Radiat Oncol Biol Phys 79:800\u2013807. https:\/\/doi.org\/10.1016\/j.ijrobp.2009.11.010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1844_CR126","doi-asserted-by":"publisher","first-page":"244","DOI":"10.3389\/fonc.2019.00244","volume":"9","author":"Y Cheng","year":"2019","unstructured":"Cheng Y, Ma Y, Zheng J, Deng H, Wang X, Li Y, Pang X, Chen H, He F, Wang L, Wang J, Wan X (2019) Impact of chemotherapy regimens on normal tissue complication probability models of acute hematologic toxicity in rectal cancer patients receiving intensity modulated radiation therapy with concurrent chemotherapy from a prospective phase III clinical trial. Front Oncol 9:244. https:\/\/doi.org\/10.3389\/fonc.2019.00244","journal-title":"Front Oncol"},{"key":"1844_CR127","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.radonc.2015.11.020","volume":"118","author":"C Sini","year":"2016","unstructured":"Sini C, Fiorino C, Perna L, Noris Chiorda B, Deantoni CL, Bianchi M, Sacco V, Briganti A, Montorsi F, Calandrino R, Di Muzio N, Cozzarini C (2016) Dose-volume effects for pelvic bone marrow in predicting hematological toxicity in prostate cancer radiotherapy with pelvic node irradiation. Radiother Oncol 118:79\u201384. https:\/\/doi.org\/10.1016\/j.radonc.2015.11.020","journal-title":"Radiother Oncol"},{"key":"1844_CR128","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13014-020-01606-3","volume":"15","author":"J Huang","year":"2020","unstructured":"Huang J, Gu F, Ji T, Zhao J, Li G (2020) Pelvic bone marrow sparing intensity modulated radiotherapy reduces the incidence of the hematologic toxicity of patients with cervical cancer receiving concurrent chemoradiotherapy: a single-center prospective randomized controlled trial. Radiat Oncol 15:1\u20139. https:\/\/doi.org\/10.1186\/s13014-020-01606-3","journal-title":"Radiat Oncol"},{"key":"1844_CR129","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.semradonc.2019.12.003","volume":"30","author":"P Lambin","year":"2020","unstructured":"Lambin P, Lieverse RIY, Eckert F, Marcus D, Oberije C, van der Wiel AMA, Guha C, Dubois LJ, Deasy JO (2020) Lymphocyte-Sparing Radiotherapy: the rationale for protecting lymphocyte-rich organs when combining radiotherapy with immunotherapy. Semin Radiat Oncol 30:187\u2013193. https:\/\/doi.org\/10.1016\/j.semradonc.2019.12.003","journal-title":"Semin Radiat Oncol"},{"key":"1844_CR130","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.ijrobp.2014.05.041","volume":"90","author":"R Carmona","year":"2014","unstructured":"Carmona R, Pritz J, Bydder M, Gulaya S, Zhu H, Williamson CW, Welch CS, Vaida F, Bydder G, Mell LK (2014) Fat composition changes in bone marrow during chemotherapy and radiation therapy. Int J Radiat Oncol Biol Phys 90:155\u2013163. https:\/\/doi.org\/10.1016\/j.ijrobp.2014.05.041","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1844_CR131","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1002\/jmri.24071","volume":"38","author":"PJ Bolan","year":"2013","unstructured":"Bolan PJ, Arentsen L, Sueblinvong T, Zhang Y, Moeller S, Carter JS, Downs LS, Ghebre R, Yee D, Froelich J, Hui S (2013) Water-fat MRI for assessing changes in bone marrow composition due to radiation and chemotherapy in gynecologic cancer patients. J Magn Reson Imaging 38:1578\u20131584. https:\/\/doi.org\/10.1002\/jmri.24071","journal-title":"J Magn Reson Imaging"},{"key":"1844_CR132","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.ijrobp.2016.06.1399","volume":"6","author":"K Khullar","year":"2016","unstructured":"Khullar K, Sudhoff M, Elson JK, Herzog T, Jackson A, Billingsley C, Lamba M, Kharofa JR (2016) A comparison of dosimetric parameters in PET-based active bone marrow volume and total bone volume in prediction of hematologic toxicity in cervical cancer patients treated with chemoradiation. J Radiat Oncol 6:161\u2013165. https:\/\/doi.org\/10.1016\/j.ijrobp.2016.06.1399","journal-title":"J Radiat Oncol"},{"key":"1844_CR133","doi-asserted-by":"publisher","first-page":"7219","DOI":"10.1002\/cam4.2601","volume":"8","author":"SB Wang","year":"2019","unstructured":"Wang SB, Liu JP, Lei KJ, Jia YM, Xu Y, Rong JF, Wang CX (2019) The volume of 99mTc sulfur colloid SPET-defined active bone marrow can predict grade 3 or higher acute hematologic toxicity in locally advanced cervical cancer patients who receive chemoradiotherapy. Cancer Med 8:7219\u20137226. https:\/\/doi.org\/10.1002\/cam4.2601","journal-title":"Cancer Med"},{"key":"1844_CR134","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ijrobp.2016.04.009","volume":"96","author":"SM McGuire","year":"2016","unstructured":"McGuire SM, Bhatia SK, Sun W, Jacobson GM, Menda Y, Ponto LL, Smith BJ, Gross BA, Bayouth JE, Sunderland JJ, Graham MM, Buatti JM (2016) Using [18F] fluorothymidine imaged with positron emission tomography to quantify and reduce hematologic toxicity due to chemoradiation therapy for pelvic cancer patients. Int J Radiat Oncol Biol Phys 96:228\u2013239. https:\/\/doi.org\/10.1016\/j.ijrobp.2016.04.009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1844_CR135","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1002\/jcb.22699","volume":"111","author":"F Mussano","year":"2010","unstructured":"Mussano F, Lee KJ, Zuk P, Tran L, Cacalano NA, Jewett A, Carossa S, Nishimura I (2010) Differential effect of ionizing radiation exposure on multipotent and differentiation-restricted bone marrow mesenchymal stem cells. J Cell Biochem 111:322\u2013332. https:\/\/doi.org\/10.1002\/jcb.22699","journal-title":"J Cell Biochem"},{"key":"1844_CR136","doi-asserted-by":"publisher","first-page":"842","DOI":"10.2174\/1389201014666131227120222","volume":"14","author":"L Fouillard","year":"2013","unstructured":"Fouillard L, Francois S, Bouchet S, Bensidhoum M, Elm\u2019selmi A, Chapel A (2013) Innovative cell therapy in the treatment of serious adverse events related to both chemo-radiotherapy protocol and acute myeloid leukemia syndrome: the infusion of mesenchymal stem cells post-treatment reduces hematopoietic toxicity and promotes hematopoietic reconstitution. Curr Pharm Biotechnol 14:842\u2013848. https:\/\/doi.org\/10.2174\/1389201014666131227120222","journal-title":"Curr Pharm Biotechnol"},{"key":"1844_CR137","doi-asserted-by":"publisher","first-page":"183","DOI":"10.7534\/j.issn.1009-2137.2014.01.035","volume":"22","author":"ZH Yang","year":"2015","unstructured":"Yang ZH, Wang XB, Wang J, Li LL, Zhu YX (2015) Influence of TLR2 and TLR4 agonists on migration of human bone marrow mesenchymal stem cells. Zhongguo Shi Yan Xue Ye Xue Za Zhi 22:183\u2013186. https:\/\/doi.org\/10.7534\/j.issn.1009-2137.2014.01.035","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"key":"1844_CR138","doi-asserted-by":"publisher","first-page":"e16874","DOI":"10.1097\/md.0000000000016874","volume":"98","author":"MD Schad","year":"2019","unstructured":"Schad MD, Moore J, Camacho F, Anderson RT, Cantrell LA, Showalter TN (2019) Predictors of quality of care and survival in a three-state cohort of locally advanced cervical cancer patients and development of a predictive model to identify women at risk of incomplete treatment. Medicine (Baltimore) 98:e16874. https:\/\/doi.org\/10.1097\/md.0000000000016874","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"1844_CR139","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.ijrobp.2016.11.027","volume":"97","author":"LK Mell","year":"2017","unstructured":"Mell LK, Sir\u00e1k I, Wei L, Tarnawski R, Mahantshetty U, Yashar CM, McHale MT, Xu R, Honerkamp-Smith G, Carmona R, Wright M (2017) Bone marrow-sparing intensity modulated radiation therapy with concurrent cisplatin for stage IB-IVA cervical cancer: an international multicenter phase II clinical trial (INTERTECC-2). Int J Radiat Oncol Bio Phys 97(3):536\u201345","journal-title":"Int J Radiat Oncol Bio Phys"},{"key":"1844_CR140","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/0360-3016(91)90171-y","volume":"21","author":"B Emami","year":"1991","unstructured":"Emami B, Lyman J, Brown A, Coia L, Goitein M, Munzenrider JE, Shank B, Solin LJ, Int WM (1991) Tolerance of normal tissue to therapeutic irradiation. J Radiat Oncol Biol Phys 21:109\u2013122. https:\/\/doi.org\/10.1016\/0360-3016(91)90171-y","journal-title":"J Radiat Oncol Biol Phys"},{"key":"1844_CR141","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1016\/j.ijrobp.2009.07.1754","volume":"76","author":"LB Marks","year":"2010","unstructured":"Marks LB, Yorke ED, Jackson A, Ten Haken RK, Constine LS, Eisbruch A, Bentzen SM, Nam J, Deasy JO (2010) Use of normal tissue complication probability models in the clinic. Int J Radiat Oncol Biol Phys 76:S10\u2013S19. https:\/\/doi.org\/10.1016\/j.ijrobp.2009.07.1754","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1844_CR142","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1088\/0031-9155\/53\/1\/002","volume":"53","author":"G Luxton","year":"2008","unstructured":"Luxton G, Keall PJ, King CR (2008) A new formula for normal tissue complication probability (NTCP) as a function of equivalent uniform dose (EUD). Phys Med Biol 53:23\u201336. https:\/\/doi.org\/10.1088\/0031-9155\/53\/1\/002","journal-title":"Phys Med Biol"},{"key":"1844_CR143","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1016\/j.ijrobp.2009.11.062","volume":"78","author":"Y Liang","year":"2010","unstructured":"Liang Y, Messer K, Rose BS, Lewis JH, Jiang SB, Yashar CM, Mundt AJ, Mell LK (2010) Impact of bone marrow radiation dose on acute hematologic toxicity in cervical cancer: principal component analysis on high dimensional data. Int J Radiat Oncol Biol Phys 78:912\u2013919. https:\/\/doi.org\/10.1016\/j.ijrobp.2009.11.062","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1844_CR144","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1120\/jacmp.v11i4.3255","volume":"11","author":"WY Song","year":"2010","unstructured":"Song WY, Huh SN, Liang Y, White G, Nichols RC, Watkins WT, Mundt AJ, Mell LK (2010) Dosimetric comparison study between intensity modulated radiation therapy and threedimensional conformal proton therapy for pelvic bone marrow sparing in the treatment of cervical cancer. J Appl Clin Med Phys 11:83\u201392. https:\/\/doi.org\/10.1120\/jacmp.v11i4.3255","journal-title":"J Appl Clin Med Phys"},{"key":"1844_CR145","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.radonc.2021.10.015","volume":"165","author":"P Zhou","year":"2021","unstructured":"Zhou P, Zhang Y, Luo S, Zhang S (2021) Pelvic bone marrow sparing radiotherapy for cervical cancer: a systematic review and meta-analysis. Radiother Oncol 165:103\u2013118. https:\/\/doi.org\/10.1016\/j.radonc.2021.10.015","journal-title":"Radiother Oncol"},{"key":"1844_CR146","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.radonc.2017.02.017","volume":"123","author":"N Li","year":"2017","unstructured":"Li N, Noticewala SS, Williamson CW, Shen H, Sirak I, Tarnawski R, Mahantshetty U, Hoh CK, Moore KL, Mell LK (2017) Feasibility of atlas-based active bone marrow sparing intensity modulated radiation therapy for cervical cancer. Radiother Oncol 123:325\u2013330. https:\/\/doi.org\/10.1016\/j.radonc.2017.02.017","journal-title":"Radiother Oncol"},{"issue":"5","key":"1844_CR147","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1016\/j.ijrobp.2020.06.071","volume":"108","author":"T Yusufaly","year":"2020","unstructured":"Yusufaly T, Miller A, Medina-Palomo A, Williamson CW, Nguyen H, Lowenstein J, Leath CA 3rd, Xiao Y, Moore KL, Moxley KM, Chevere-Mourino CM, Eng TY, Zaid T, Mell LK (2020) A multi-atlas approach for active bone marrow sparing radiation therapy: implementation in the NRG-GY006 trial. Int J Radiat Oncol Biol Phys. 108(5):1240\u20131247. https:\/\/doi.org\/10.1016\/j.ijrobp.2020.06.071","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"1844_CR148","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.prro.2017.07.001","volume":"8","author":"K Yan","year":"2018","unstructured":"Yan K, Ramirez E, Xie X-J, Gu X, Xi Y, Albuquerque K (2018) Predicting severe hematologic toxicity from extended-field chemoradiation of para-aortic nodal metastases from cervical cancer. Pract Radiat Oncol 8:13\u201319. https:\/\/doi.org\/10.1016\/j.prro.2017.07.001","journal-title":"Pract Radiat Oncol"},{"key":"1844_CR149","doi-asserted-by":"publisher","first-page":"100998","DOI":"10.1016\/j.adro.2022.100998","volume":"7","author":"JHL Hara","year":"2022","unstructured":"Hara JHL, Jutzy JMS, Arya R, Kothari R, McCall AR, Howard AR, Hasan Y, Cursio JF, Son CH (2022) Predictors of acute hematologic toxicity in women receiving extended-field chemoradiation for cervical cancer: Do known pelvic radiation bone marrow constraints apply? Adv Radiat Oncol 7:100998. https:\/\/doi.org\/10.1016\/j.adro.2022.100998","journal-title":"Adv Radiat Oncol"},{"key":"1844_CR150","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.ijrobp.2013.01.017","volume":"86","author":"AH Klopp","year":"2013","unstructured":"Klopp AH, Moughan J, Portelance L, Miller BE, Salehpour MR, Hildebrandt E, Nuanjing J, D\u2019Souza D, Souhami L, Small W Jr, Gaur R, Jhingran A (2013) Hematologic toxicity in RTOG 0418: a phase 2 study of postoperative IMRT for gynecologic cancer. Int J Radiat Oncol Biol Phys 86:83\u201390. https:\/\/doi.org\/10.1016\/j.ijrobp.2013.01.017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1844_CR151","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.radonc.2021.09.009","volume":"164","author":"A Corbeau","year":"2021","unstructured":"Corbeau A, Kuipers SC, de Boer SM, Horeweg N, Hoogeman MS, Godart J, Nout RA (2021) Correlations between bone marrow radiation dose and hematologic toxicity in locally advanced cervical cancer patients receiving chemoradiation with cisplatin: a systematic review. Radiother Oncol. 164:128\u2013137. https:\/\/doi.org\/10.1016\/j.radonc.2021.09.009","journal-title":"Radiother Oncol."},{"key":"1844_CR152","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/j.ijrobp.2014.08.017","volume":"90","author":"O Elicin","year":"2014","unstructured":"Elicin O, Callaway S, Prior JO, Bourhis J, Ozsahin M, Herrera FG (2014) [18F] FDG-PET standard uptake value as a metabolic predictor of bone marrow response to radiation: impact on acute and late hematological toxicity in cervical cancer patients treated with chemoradiation therapy. Int J Radiat Oncol Biol Phys 90:1099\u20131107. https:\/\/doi.org\/10.1016\/j.ijrobp.2014.08.017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1844_CR153","doi-asserted-by":"publisher","first-page":"20170398","DOI":"10.1259\/bjr.20170398","volume":"91","author":"HC Luo","year":"2018","unstructured":"Luo HC, Lin GS, Liao SG, Wang FM, Cheng HH, Feng J, Yin Q, Chen QH, Zhu JF, Xu JF, Wang D, Fu ZC (2018) Cervical cancer treated with reduced-volume intensity-modulated radiation therapy base on Sedlis criteria (NCCN VS RTOG). Br J Radiol 91:20170398. https:\/\/doi.org\/10.1259\/bjr.20170398","journal-title":"Br J Radiol"},{"key":"1844_CR154","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.radonc.2021.02.029","volume":"158","author":"C Terrones-Campos","year":"2021","unstructured":"Terrones-Campos C, Ledergerber B, Vogelius IR, Helleberg M, Specht L, Lundgren J (2021) Hematological toxicity in patients with solid malignant tumors treated with radiation\u2014Temporal analysis, dose response and impact on survival. Radiother Oncol 158:175\u2013183. https:\/\/doi.org\/10.1016\/j.radonc.2021.02.029","journal-title":"Radiother Oncol"},{"key":"1844_CR155","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.3390\/medicina58091223","volume":"58","author":"F Tramacere","year":"2022","unstructured":"Tramacere F, Lancellotta V, Cas\u00e0 C et al (2022) Assessment of sexual dysfunction in cervical cancer patients after different treatment modality: a systematic review. Medicina 58:1223","journal-title":"Medicina"},{"key":"1844_CR156","doi-asserted-by":"publisher","first-page":"3932","DOI":"10.3390\/ijerph18083932","volume":"18","author":"A Wierzbicka","year":"2021","unstructured":"Wierzbicka A, Wierzbicka DM, Cieslewicz S, Mardas MS, Mardas M (2021) Interventions preventing vaginitis, vaginal atrophy after brachytherapy or radiotherapy due to malignant tumors of the female reproductive organs-a systematic review. Int J Environ Res Public Health 18:3932. https:\/\/doi.org\/10.3390\/ijerph18083932","journal-title":"Int J Environ Res Public Health"},{"issue":"2","key":"1844_CR157","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.ijrobp.2021.08.036","volume":"112","author":"K Kirchheiner","year":"2022","unstructured":"Kirchheiner K, Smet S, J\u00fcrgenliemk-Schulz IM, Haie-Meder C, Chargari C, Lindegaard JC, Fokdal LU, Spampinato S, Schmid MP, Sturdza A, Mahantshetty U (2022) Impact of vaginal symptoms and hormonal replacement therapy on sexual outcomes after definitive chemoradiotherapy in patients with locally advanced cervical cancer: results from the EMBRACE-I study. Int J Radiat Oncol Bio Phys 112(2):400\u201313","journal-title":"Int J Radiat Oncol Bio Phys"},{"key":"1844_CR158","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.radonc.2016.05.020","volume":"120","author":"S Mohamed","year":"2016","unstructured":"Mohamed S, Lindegaard JC, de Leeuw AA, J\u00fcrgenliemk-Schulz I, Kirchheiner K, Kirisits C, P\u00f6tter R, Tanderup K (2016) Vaginal dose de-escalation in image guided adaptive brachytherapy for locally advanced cervical cancer. Radiother Oncol 120:480\u2013485. https:\/\/doi.org\/10.1016\/j.radonc.2016.05.020","journal-title":"Radiother Oncol"},{"key":"1844_CR159","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.radonc.2012.04.018","volume":"103","author":"LH Barraclough","year":"2012","unstructured":"Barraclough LH, Routledge JA, Farnell DJ, Burns MP, Swindell R, Livsey JE, Davidson SE (2012) Prospective analysis of patient-reported late toxicity following pelvic radiotherapy for gynaecological cancer. Radiother Oncol 103:327\u2013332. https:\/\/doi.org\/10.1016\/j.radonc.2012.04.018","journal-title":"Radiother Oncol"},{"key":"1844_CR160","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/j.brachy.2017.05.001","volume":"16","author":"KM Thomas","year":"2017","unstructured":"Thomas KM, Maquilan G, Stojadinovic S, Medin P, Folkert MR, Albuquerque K (2017) Reduced toxicity with equivalent outcomes using three-dimensional volumetric(3DV) image-based versus nonvolumetric point-based (NV) brachytherapy in a cervical cancer population. Brachytherapy 16:943\u2013948. https:\/\/doi.org\/10.1016\/j.brachy.2017.05.001","journal-title":"Brachytherapy"},{"key":"1844_CR161","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.radonc.2021.12.034","volume":"168","author":"H Westerveld","year":"2022","unstructured":"Westerveld H, Kirchheiner K, Nout RA, Tanderup K, Lindegaard JC, Spampinato S, Sturdza A, Nesvacil N, Bruheim K, Hellebust TP, Pieters BR, Kirisits C, J\u00fcrgenliemk-Schulz IM, P\u00f6tter R, de Leeuw AAC (2022) Dose-effect relationship between vaginal dose points and vaginal stenosis in cervical cancer: an EMBRACE-I sub-study. Radiother Oncol 168:8\u201315. https:\/\/doi.org\/10.1016\/j.radonc.2021.12.034","journal-title":"Radiother Oncol"},{"issue":"1","key":"1844_CR162","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.radonc.2015.12.025","volume":"118","author":"K Kirchheiner","year":"2016","unstructured":"Kirchheiner K, Nout RA, Lindegaard JC, Haie-Meder C, Mahantshetty U, Segedin B, J\u00fcrgenliemk-Schulz IM, Hoskin PJ, Rai B, D\u00f6rr W, Kirisits C (2016) Dose\u2013effect relationship and risk factors for vaginal stenosis after definitive radio (chemo) therapy with image-guided brachytherapy for locally advanced cervical cancer in the EMBRACE study. Radiother oncol 118(1):160\u20136","journal-title":"Radiother oncol"},{"key":"1844_CR163","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.radonc.2013.04.009","volume":"107","author":"H Westerveld","year":"2013","unstructured":"Westerveld H, P\u00f6tter R, Berger D, Dankulchai P, D\u00f6rr W, Sora MC, P\u00f6tter-Lang S, Kirisits C (2013) Vaginal dose point reporting in cervical cancer patients treated with combined 2D\/3D external beam radiotherapy and 2D\/3D brachytherapy. Radiother Oncol 107:99\u2013105. https:\/\/doi.org\/10.1016\/j.radonc.2013.04.009","journal-title":"Radiother Oncol"},{"key":"1844_CR164","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.2217\/fon-2016-0121","volume":"12","author":"FE Duncan","year":"2016","unstructured":"Duncan FE, Kimler BF, Briley SM (2016) Combating radiation therapy-induced damage to the ovarian environment. Future Oncol 12:1687\u20131690. https:\/\/doi.org\/10.2217\/fon-2016-0121","journal-title":"Future Oncol"},{"key":"1844_CR165","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.clon.2016.08.016","volume":"28","author":"EL Moss","year":"2016","unstructured":"Moss EL, Taneja S, Munir F, Kent C, Robinson L, Potdar N, Sarhanis P, McDermott H (2016) Iatrogenic menopause after treatment for cervical cancer. Clin Oncol (R Coll Radiol) 28:766\u2013775. https:\/\/doi.org\/10.1016\/j.clon.2016.08.016","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"1844_CR166","doi-asserted-by":"publisher","first-page":"918899","DOI":"10.3389\/fendo.2022.918899","volume":"13","author":"AA Diaz","year":"2022","unstructured":"Diaz AA, Kubo H, Handa N, Hanna M, Laronda MM (2022) A systematic review of ovarian tissue transplantation outcomes by ovarian tissue processing size for cryopreservation. Front Endocrinol (Lausanne) 13:918899. https:\/\/doi.org\/10.3389\/fendo.2022.918899","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1844_CR167","first-page":"523","volume":"67","author":"S Dinicola","year":"2015","unstructured":"Dinicola S, Pasta V, Costantino D, Guaraldi C, Bizzarri M (2015) Hyaluronic acid and vitamins are effective in reducing vaginal atrophy in women receiving radiotherapy. Minerva Ginecol 67:523\u2013531","journal-title":"Minerva Ginecol"},{"key":"1844_CR168","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1159\/000496036","volume":"42","author":"P Delia","year":"2019","unstructured":"Delia P, Sansotta G, Pontoriero A, Iati G, De Salvo S, Pisana M, Potami A, Lopes S, Messina G, Pergolizzi S (2019) Clinical evaluation of low-molecular-weight hyaluronic acid-based treatment on onset of acute side effects in women receiving adjuvant radiotherapy after cervical surgery: a randomized clinical trial. Oncol Res Treat 42:217\u2013223. https:\/\/doi.org\/10.1159\/000496036","journal-title":"Oncol Res Treat"},{"key":"1844_CR169","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1097\/igc.0b013e318223659d","volume":"21","author":"A Galuppi","year":"2011","unstructured":"Galuppi A, Perrone AM, La Macchia M, Santini D, Medoro S, Maccarini LR, Strada I, Pozzati F, Rossi M, De Iaco P (2011) Local \u03b1-tocopherol for acute and short-term vaginal toxicity prevention in patients treated with radiotherapy for gynecologic tumors. Int J Gynecol Cancer 21:1708\u20131711. https:\/\/doi.org\/10.1097\/igc.0b013e318223659d","journal-title":"Int J Gynecol Cancer"},{"key":"1844_CR170","doi-asserted-by":"publisher","first-page":"512","DOI":"10.5114\/jcb.2016.64511","volume":"8","author":"C Laliscia","year":"2016","unstructured":"Laliscia C, Delishaj D, Fabrini MG, Gonnelli A, Morganti R, Perrone F, Tana R, Paiar F, Gadducci A (2016) Acute and late vaginal toxicity after adjuvant high-dose-rate vaginal brachytherapy in patients with intermediate risk endometrial cancer: is local therapy with hyaluronic acid of clinical benefit? J Contemp Brachytherapy 8:512\u2013517. https:\/\/doi.org\/10.5114\/jcb.2016.64511","journal-title":"J Contemp Brachytherapy"},{"key":"1844_CR171","first-page":"356","volume":"27","author":"J Sobotkowski","year":"2006","unstructured":"Sobotkowski J, Markowska J, Fijuth J, Pietraszek A (2006) Preliminary results of mitomycin C local application as post-treatment prevention of vaginal radiation-induced morbidity in women with cervical cancer. Eur J Gynaecol Oncol 27:356\u2013358","journal-title":"Eur J Gynaecol Oncol"},{"key":"1844_CR172","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1097\/gme.0000000000000329","volume":"21","author":"DJ Portman","year":"2014","unstructured":"Portman DJ, Gass ML (2014) Vulvovaginal Atrophy Terminology Consensus Conference Panel. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the study of women\u2019s sexual health and the North American menopause society. Menopause 21:1063\u20131068. https:\/\/doi.org\/10.1097\/gme.0000000000000329","journal-title":"Menopause"},{"issue":"7","key":"1844_CR173","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1097\/GME.0000000000002028","volume":"29","author":"SS Faubion","year":"2022","unstructured":"Faubion SS, Crandall CJ, Davis L, El Khoudary SR, Hodis HN, Lobo RA, Maki PM, Manson JE, Pinkerton JV, Santoro NF, Shifren JL (2022) The 2022 hormone therapy position statement of the North American menopause society. Menopause. 29(7):767\u201394","journal-title":"Menopause."},{"key":"1844_CR174","first-page":"1341","volume":"30","author":"K Bodner","year":"2010","unstructured":"Bodner K, Laubichler P, Kimberger O, Czerwenka K, Zeillinger R, Bodner-Adler B (2010) Oestrogen and progesterone receptor expression in patients with adenocarcinoma of the uterine cervix and correlation with various clinicopathological parameters. Anticancer Res 30:1341\u20131345","journal-title":"Anticancer Res"},{"key":"1844_CR175","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1097\/gme.0000000000000357","volume":"22","author":"\u00c5H Everhov","year":"2015","unstructured":"Everhov \u00c5H, Nyberg T, Bergmark K, Citarella A, R\u00e5destad AF, Hirschberg AL, Smedby KE (2015) Hormone therapy after uterine cervical cancer treatment: a Swedish population-based study. Menopause 22:633\u2013639. https:\/\/doi.org\/10.1097\/gme.0000000000000357","journal-title":"Menopause"},{"key":"1844_CR176","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.maturitas.2004.07.005","volume":"51","author":"JA de Hullu","year":"2005","unstructured":"de Hullu JA, Pras E, Hollema H, van der Zee AG, Bogchelman DH, Mourits MJ (2005) Presentations of endometrial activity after curative radiotherapy for cervical cancer. Maturitas 51:172\u2013176. https:\/\/doi.org\/10.1016\/j.maturitas.2004.07.005","journal-title":"Maturitas"},{"key":"1844_CR177","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1258\/175404507780456719","volume":"13","author":"J Pitkin","year":"2007","unstructured":"Pitkin J, Rees MC, Gray S, Lumsden MA, Marsden J, Stevenson JC, Williamson J (2007) Management of premature menopause. Menopause Int 13:44\u201345. https:\/\/doi.org\/10.1258\/175404507780456719","journal-title":"Menopause Int"},{"key":"1844_CR178","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1016\/j.ejca.2014.03.006","volume":"50","author":"SH Shim","year":"2014","unstructured":"Shim SH, Lee SJ, Kim SN (2014) Effects of hormone replacement therapy on the rate of recurrence in endometrial cancer survivors: a meta-analysis. Eur J Cancer 50:1628\u20131637. https:\/\/doi.org\/10.1016\/j.ejca.2014.03.006","journal-title":"Eur J Cancer"},{"key":"1844_CR179","doi-asserted-by":"publisher","first-page":"813352","DOI":"10.3389\/fmed.2021.813352","volume":"8","author":"A Barcellini","year":"2022","unstructured":"Barcellini A, Dominoni M, Dal Mas F, Biancuzzi H, Venturini SC, Gardella B, Orlandi E, B\u00f8 K (2022) Sexual health dysfunction after radiotherapy for gynecological cancer: role of physical rehabilitation including pelvic floor muscle training. Front Med (Lausanne) 8:813352. https:\/\/doi.org\/10.3389\/fmed.2021.813352","journal-title":"Front Med (Lausanne)"},{"key":"1844_CR180","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.3390\/cancers12061639","volume":"12","author":"AM Perrone","year":"2020","unstructured":"Perrone AM, Tesei M, Ferioli M, De Terlizzi F, Della Gatta AN, Boussedra S, Dondi G, Galuppi A, Morganti AG, De Iaco P (2020) Results of a phase I-II study on laser therapy for vaginal side effects after radiotherapy for cancer of uterine cervix or endometrium. Cancers (Basel) 12:1639. https:\/\/doi.org\/10.3390\/cancers12061639","journal-title":"Cancers (Basel)"},{"key":"1844_CR181","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1186\/s12885-021-08274-w","volume":"21","author":"J Martins","year":"2021","unstructured":"Martins J, Vaz AF, Grion RC, Costa-Paiva L, Baccaro LF (2021) Topical estrogen, testosterone, and vaginal dilator in the prevention of vaginal stenosis after radiotherapy in women with cervical cancer: a randomized clinical trial. BMC Cancer 21:682. https:\/\/doi.org\/10.1186\/s12885-021-08274-w","journal-title":"BMC Cancer"},{"key":"1844_CR182","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1111\/j.1471-0528.2010.02502.x","volume":"117","author":"N Johnson","year":"2010","unstructured":"Johnson N, Miles TP, Cornes P (2010) Dilating the vagina to prevent damage from radiotherapy: systematic review of the literature. BJOG 117:522\u2013531. https:\/\/doi.org\/10.1111\/j.1471-0528.2010.02502.x","journal-title":"BJOG"},{"issue":"6","key":"1844_CR183","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.prro.2019.07.001","volume":"9","author":"S Damast","year":"2019","unstructured":"Damast S, Jeffery DD, Son CH et al (2019) Literature review of vaginal stenosis and dilator use in radiation oncology. Pract Radiat Oncol 9(6):479\u2013491. https:\/\/doi.org\/10.1016\/j.prro.2019.07.001","journal-title":"Pract Radiat Oncol"},{"key":"1844_CR184","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1007\/s12094-023-03099-4","volume":"25","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Noorian F, Abellana R et al (2023) Vaginal dilator use more than 9 months is a main prognostic factor for reducing G2-late vaginal complications in 3D-vaginal-cuff brachytherapy (interventional radiotherapy)? Clin Transl Oncol 25:1748\u20131755. https:\/\/doi.org\/10.1007\/s12094-023-03099-4","journal-title":"Clin Transl Oncol"},{"key":"1844_CR185","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1007\/s12325-019-01006-4","volume":"36","author":"TM Cerentini","year":"2019","unstructured":"Cerentini TM, Schl\u00f6ttgen J, Viana da Rosa P, La Rosa VL, Vitale SG, Giampaolino P, Valenti G, Cianci S, Macagnan FE (2019) Clinical and psychological outcomes of the use of vaginal dilators after gynaecological brachytherapy: a randomized clinical trial. Adv Ther 36:1936\u20131949. https:\/\/doi.org\/10.1007\/s12325-019-01006-4","journal-title":"Adv Ther"},{"key":"1844_CR186","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1111\/aogs.14310","volume":"101","author":"M Seland","year":"2022","unstructured":"Seland M, Skrede K, Lindemann K, Skaali T, Blomhoff R, Bruheim K, Wisl\u00f8ff T, Thorsen L (2022) Distress, problems and unmet rehabilitation needs after treatment for gynecological cancer. Acta Obstet Gynecol Scand 101:313\u2013322. https:\/\/doi.org\/10.1111\/aogs.14310","journal-title":"Acta Obstet Gynecol Scand"},{"key":"1844_CR187","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.ijrobp.2015.08.023","volume":"93","author":"SM de Boer","year":"2015","unstructured":"de Boer SM, Nout RA, J\u00fcrgenliemk-Schulz IM, Jobsen JJ, Lutgens LC, van der Steen-Banasik EM, Mens JW, Slot A, Stenfert Kroese MC, Oerlemans S, Putter H, Verhoeven-Adema KW, Nijman HW, Creutzberg CL (2015) Long-term impact of endometrial cancer diagnosis and treatment on health-related quality of life and cancer survivorship: results from the randomized PORTEC-2 Trial. Int J Radiat Oncol Biol Phys 93:797\u2013809. https:\/\/doi.org\/10.1016\/j.ijrobp.2015.08.023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1844_CR188","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1016\/j.ijrobp.2015.12.363","volume":"94","author":"K Kirchheiner","year":"2016","unstructured":"Kirchheiner K, P\u00f6tter R, Tanderup K, Lindegaard JC, Haie-Meder C, Petri\u010d P, Mahantshetty U, J\u00fcrgenliemk-Schulz IM, Rai B, Cooper R, D\u00f6rr W, Nout RA (2016) EMBRACE Collaborative GroupHealth-related quality of life in locally advanced cervical cancer patients after definitive chemoradiation therapy including image guided adaptive brachytherapy: an analysis from EMBRACE study. Int J Radiat Oncol Biol Phys 94:1088\u20131098. https:\/\/doi.org\/10.1016\/j.ijrobp.2015.12.363","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1844_CR189","unstructured":"https:\/\/www.redjournal.org\/article\/S0360-3016(04)01224-6\/fulltext"},{"key":"1844_CR190","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.critrevonc.2014.12.015","volume":"94","author":"R Hymel","year":"2015","unstructured":"Hymel R, Jones GC, Simone CB II (2015) Whole pelvic intensity-modulated radiotherapy for gynaecological malignancies: a review of the literature. Crit Rev Oncol Hematol 94:371\u2013379. https:\/\/doi.org\/10.1016\/j.critrevonc.2014.12.015","journal-title":"Crit Rev Oncol Hematol"},{"key":"1844_CR191","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.rpor.2013.08.001","volume":"18","author":"A Fernandez-Ots","year":"2013","unstructured":"Fernandez-Ots A, Crook J (2013) The role of intensity modulated radiotherapy in gynaecological radiotherapy: present and future. Rep Pract Oncol Radiother 18:363\u2013370. https:\/\/doi.org\/10.1016\/j.rpor.2013.08.001","journal-title":"Rep Pract Oncol Radiother"},{"key":"1844_CR192","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.ijrobp.2016.11.008","volume":"97","author":"P Holch","year":"2017","unstructured":"Holch P, Henry AM, Davidson S et al (2017) Acute and late adverse events associated with radical radiation therapy prostate cancer treatment: a systematic review of clinician and patient toxicity reporting in randomized controlled trials. Int J Radiat Oncol Biol Phys 97:495\u2013510. https:\/\/doi.org\/10.1016\/j.ijrobp.2016.11.008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1844_CR193","doi-asserted-by":"publisher","first-page":"3306","DOI":"10.3390\/curroncol29050270","volume":"29","author":"M Chan","year":"2022","unstructured":"Chan M, Olson R, Lapointe V, Hamm J, Bachand F, Holloway C, Parsons C, Lim P (2022) Using a weekly patient-reported outcome questionnaire to track acute toxicity in patients undergoing pelvic radiotherapy for gynecologic cancers. Curr Oncol 29:3306\u20133317. https:\/\/doi.org\/10.3390\/curroncol29050270","journal-title":"Curr Oncol"}],"container-title":["La radiologia medica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11547-024-01844-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11547-024-01844-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11547-024-01844-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T12:15:01Z","timestamp":1725624901000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11547-024-01844-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,28]]},"references-count":193,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2024,9]]}},"alternative-id":["1844"],"URL":"https:\/\/doi.org\/10.1007\/s11547-024-01844-5","relation":{},"ISSN":["1826-6983"],"issn-type":[{"value":"1826-6983","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,28]]},"assertion":[{"value":"7 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Authors disclose no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Institutional Review Board approval was not required because this study does not involve human subjects.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was not applicable for this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All authors agreed on the content of the paper.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}